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ABSTRACT 
 Gold nanoparticles have attracted great interest in the last decade for applications in 
biochemical detection, imaging, and therapeutics, due to their useful optoelectronic properties.  
Interest in this area has recently focused on engineering the surface of the nanoparticles, because 
of the ease in which the charge, functionality, and reactivity of the surface can be altered.  This 
dissertation will focus on the applications of surface-engineered gold nanoparticles in chemical 
detection and biomedical imaging, and look at the effects surface modified gold nanorods have 
on the behavior of cardiac fibroblasts in tissue culture. 
 As an alternative to solution-based techniques in Raman spectroscopy, we have found 
that a sandwich architecture in which a surface assembled monolayer (SAM) of 4-
mercaptobenzoic acid (4-MBA) is sandwiched between a 100 nm thick gold substrate and 
electrostaticaly immobilized gold nanocubes allows for more reproducible data as well as 
enhancement factors up to 1013. The sandwich architecture creates a large electromagnetic field 
in the area where the 4-MBA molecules reside causing the characteristic vibrational modes of 4-
MBA to appear.  We have also moved out of the realm of chemical sensing and have used our 
gold nanorods as point sensors to monitor the mechanical properties associated with 
mechanotransduction. 
Cell behavior in the presence of nanomaterials is typically explored through simple 
viability assays, but there is mounting evidence that nanomaterials can have more subtle effects 
on a variety of cell functions.  Numerous studies have documented the cellular uptake and 
cytotoxicity of gold nanoparticles in different cell types, but very little is known about how 
nanoparticles affect cellular function.  We have shown that gold nanorods in a collagen thin film 
can be used to measure the local mechanical fields near and between living cells as they assess, 
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adapt, and rearrange their environment.  We have also found that gold nanorods in 3-D tissue 
culture interfere with the cardiac fibroblast-mediated remodeling of a collagen tissue construct.  
We have found several factors associated with the dose dependent decrease in cell-mediated 
collagen remodeling including the alteration of fibroblast phenotype, adsorption of cellular 
proteins needed for cell mediated remodeling, as well as a change in the mechanical properties of 
the tissue construct.  The following chapters will detail the use of our gold nanomaterials as both 
biochemical and imaging agents, and discuss cell behavior in the presence of surface modified 
gold nanorods. 
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Chapter 1 
 
An Introduction to Gold Nanoparticles 
 
1.1 Introduction 
 Gold has been considered to be of great value for centuries due to its ornamental value 
and putative healing powers.1-3  Ancient roman artisans used finely divided gold to create intense 
shades of red, yellow, and purple in plain glass as well as pottery glazes.  However, it was not 
until 1857 that it was found, by Michael Faraday, that the red color in stained glass was due to 
the small size of the gold particles.  He was the first to chemically synthesize solutions of 
colloidal gold, many of which can still be seen to this day on display at the Faraday Museum, 
London.3  Despite the synthesis of colloidal gold by Michael Faraday in 1857 scientists did not 
start thinking about nanotechnology until 1959 when Richard Feynman gave his famous talk 
“There’s Plenty of Room at the Bottom.”  In this talk Feynman describes his visions of building 
circuits on the nanometer scale to create more powerful computers, as well as, predicts the 
presence of nanomaterials in biological systems.4 
 Nanoscale particles are defined as particles with at least one dimension at or below 100 
nm.  Gold nanoparticles with a diameter ranging from 5-200 nm are large enough to support a 
conduction band, similar to the mean free path of electrons in a metal at room temperature, but 
the particles themselves are much smaller than the wavelength of visible light (400-700 nm).  In 
1908 Gustav Mie published a seminal paper in which the optical properties of metal spheres 
were explained by the solutions to Maxwell’s equations under the appropriate conditions.5  In 
general, upon the introduction of incident electromagnetic (EM) radiation of a given wavelength 
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the electrons present on the metal surface collectively oscillate to produce what is now generally 
termed the localized surface Plasmon resonance (LSPR).6  The unique optical properties of metal 
nanoparticles are generated by the LSPR. In recent years, Mie theory has been extended to 
explain the even more interesting optical properties of one-dimensional (1-D) metal 
nanostructures where the short axis is in the 1-100 nm regime while the longer axis might reach 
several microns in length.7  The resulting anisotropic nature of these materials results in the 
evolution of multiple plasmons at differing wavelengths due to EM radiation being absorbed  
both along the short axis (transverse plasmon band) and along the long axis (longitudinal 
plasmon band) of the metallic nanoparticles (Figure 1.1).  As a result of this phenomenon, 
changing the aspect ratio or morphology of gold or silver nanoparticles changes the position 
and/or number of plasmon bands.  In addition, because of the high surface area to volume ratio 
of gold nanoparticles, changing the local dielectric constant achieved by chemically changing the 
surface of the nanoparticles or by introducing the particles into a different medium will also 
change the position of the plasmon bands thereby changing the nanoparticle’s optical properties.  
The ability to tune the optical properties of these nanoparticles makes them extremely useful in 
biomedical research in biosensing8, cell tracking9, imaging10,11, drug delivery12, and 
therapeutics.13 
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Figure 1.1  (left) TEM micrographs of gold nanorods ~ aspect ratio 18 (center) Photographs of 
gold nanorods as a function of increasing aspect ratio from 1-5 (scale bars 100 nm).  Above the 
picture of the solutions are TEM micrographs of gold nanorods from aspect ratio 1-5.  Below the 
nanorod solution picture are the corresponding optical spectra.  (right) TEM micrograph of gold 
nanocubes. 
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1.2 Chemical Synthesis of Gold Nanorods Nanocubes 
We and others use a seed-mediated growth mechanism to make our gold nanoparticles.  
In general, chloroauric acid (HAuCl4) is reduced in the presence of the strong reducing agent 
sodium borohydride (NaBH4) in water and air at room temperature and pressure to yield a 3.5-4 
nm spherical seeding particle.  These seeding particles are then added to a growth solution that 
contains more gold salt, ascorbic acid, and our growth-directing agent 
hexadecyltrimethylammonium bromide (CTAB).  The growth solution used will determine the 
morphology of the final particle.  Ascorbic acid is not a strong enough reducing agent to reduce 
the gold ions from Au3+ to metallic gold alone but instead leaves it at Au1+.  Upon the addition of 
the seeding particles the potential necessary to reduce Au1+ to Au is reduced allowing the 
controlled growth of nanoparticles by the reduction of Au1+ to metallic gold at the surface of the 
seed. 
Long gold nanorods with diameters ranging from 20-22 nm and lengths from 350-500 nm 
as well as gold nanocubes with edge length ~50 nm can both be prepared by simply varying the 
amounts of CTAB, seeding solution, and ascorbic acid present in the growth solution.14-31  For 
long gold nanorods we have experimentally determined that a 0.1 M concentration of CTAB is 
required for successful rod formation due to the binding nature of CTAB to the surface of the 
growing nanoparticle.32  In the long rod mechanism once the seed grows large enough to support 
a bilayer of CTAB the sides of the growing particle will become passivated with CTAB, leaving 
only the ends open for reaction with the gold salt.32  This leads to the rod-like morphology and 
also explains the uniform rod width.  The overall procedure for long rod growth can be seen in 
Figure 1.2.  For the synthesis of gold nanocubes we simply ramp up the amount of ascorbic acid 
present in solution and drastically decrease both the amount of seeding particles and CTAB 
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present in the growth solution.26,31  The synthesis of these particles can be thought of much like 
baking by using the same ingredients in differing amounts we can make long rods or cubes.  
Additionally, our lab has found that the addition of Ag ions into the growth medium yields >98% 
rods of one aspect ratio.  The long rod procedure, which does not use silver, only yields about 
40% gold nanorods.  However, this comes at a price, the addition of silver into the reaction 
mixture prevents the rods from growing past an aspect ratio of 5.  We believe that this is due to 
slow silver deposition at the ends of the rods.15,16  
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Figure 1.2:  Three-step seeding protocol that yields gold nanorods (~aspect ratio 18).  Shown at 
the right of the figure is a TEM micrograph of the final nanorods as well as a cartoon showing 
the bilayer of CTAB on the surface of the nanorods. 
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1.3 SERS Using Gold Nanocubes 
Surface enhanced Raman scattering (SERS) spectroscopy is a powerful technique to 
obtain vibrational information about molecules on or near a nanoscale metallic surface.33  Since 
the introduction of SERS on roughened silver electrodes in 1977,34,35 there has been a great deal 
of research to maximize the Raman signals from adsorbates on gold and silver substrates.  
Recent developments in the controlled synthesis of gold and silver nanomaterials of different 
shapes and sizes have led to a renewed interest in SERS.36-50 The ability to tune the plasmon 
band of gold nanoparticles to a specific excitation wavelength by changing the size, shape, or 
aggregation state of the material allows one to obtain maximum Raman enhancement.  It has also 
been calculated that the high curvature associated with nanoscale materials such as gold 
nanocubes results in high surface electromagnetic fields giving particularly high enhancements 
known as “the lightning rod effect.”51   The enhancement factors associated with the SERS 
techniques are a result of two factors, the chemical enhancement and electric field enhancement 
with a large majority of the contribution coming from the latter.52,53  The mechanism of chemical 
enhancement results from a resonance-charge transfer between the surface of the gold 
nanoparticle and the Raman active molecule causing an increase in the polarizability of the 
molecule which in turn increases the molecules Raman scattering.  Large electromagnetic fields 
are generated at the surface of the nanoparticles as a response to incident light on the sample.  
This enhancement field interacts with the analyte near the surface of the nanomaterial thereby 
causing the enhancements seen in the analytes’ Raman scattering.  The electromagnetic fields 
from multiple particles can be brought together in a junction between nanoparticles to create 
massive field enhancements which can allow for single molecule detection.36,38 
8 
 Previous work from our lab has focused on two main questions: “Which shape of gold 
nanoparticle is best for SERS?” and “Is it best to perform Raman measurements in solution or on 
a flat substrate?”  It was found that gold nanocubes electrostatically immobilized on a self-
assembled monolayer (SAM) of 4-mercaptobenzoic acid (4-MBA) (Scheme 1.1) gave the 
highest enhancement factors (109-fold increase in signal compared to normal Raman of a 
solution of 4-MBA). The SERS enhancements seen with this sandwich geometry originate from 
the plasmon coupling between the localized surface plasmon of the nanoparticles and the surface 
plasmon of the gold substrate, creating a large local electromagnetic field for the molecules 
between the planar substrate and the nanoparticles.49  The flat substrate ended up being the best 
because it reduces the uncertainties in estimating the number of molecules and junctions 
sampled.  In the work described in this thesis we investigate the effects of gold nanocube 
aggregation and increased surface coverage on the enhancement of the Raman signal for 4-MBA 
in this sandwich architecture. 
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Scheme 1.1: Schematic showing the gold nanocubes electrostatically immobilized on a self-
assembled monolayer (SAM) of 4-mercaptobenzoic acid (4-MBA). 
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1.4 Biological Imaging and Effects of Gold Nanorods During Cell Culture 
 The plasmon bands associated with gold nanorods allow for their use in optical 
microscopy to image particle location.54-68  Multiple techniques have been used over the past 
several years to image nanorods in living systems including darkfield microscopy, two photon 
luminescence (TPL), confocal reflectance microscopy, and differential interference contrast 
microscopy (DIC).54-68  TPL has been used for in vivo imaging of the targeting of cancer cells in 
a mouse ear by modified gold nanorods.64  Dark field microscopy, confocal reflectance 
microscopy, and DIC are used in our research to monitor the spatial positions of gold nanorods.  
In dark field microscopy steady-state white light is projected onto the sample from around the 
objective.  The transmitted white light is then blocked so that only the scattered light from the 
nanorods is visible.  An example of a dark field image of gold nanorods in collagen can be seen 
in Figure 1.3.  As a result of the light scattering from the nanoparticles in a cone the points of 
light are much larger than the nanoparticles, resulting in our ability to see single nanorods in a 
matrix by dark field microscopy with a spatial resolution around 200 nm.  Confocal microscopy 
in reflectance mode similar to dark field microscopy uses the light scattered by the nanorods to 
image them.  DIC is a completely separate technique in which polarized light is separated into 
two light rays polarized at 90o to each other.  The two rays pass through the sample at adjacent 
areas, which are spatially displaced at the sample plane.  Before the light hits the detector the two 
rays of light are recombined which leads to brightening or darkening of the image at points 
according to differences in the optical light path. An example of images obtained using confocal 
reflectance and DIC can be seen in Figure 1.4. 
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Figure 1.3: Darkfield image of Rayleigh scattering from gold nanorods in a collagen tissue 
construct. 
12 
 
Figure 1.4: (left) Confocal reflectance microscopy image showing gold nanorods (pink) as well 
as cardiac fibroblasts (actin stained green, nuclei stained blue). (right) DIC image showing gold 
nanorods in a collagen tissue construct.  The collagen microstructure can also be seen in this 
image. 
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Using our nanorods in imaging experiments assumes that they are completely 
biocompatible with the cell lines being used. It has been found that in collagen thin film 
experiments as-prepared CTAB capped nanorods have little to no effect on the cells.  However, 
when the experiments transition into 3-D tissue scaffolds the intimate mixing of nanomaterial 
with the cells causes cell death.  This cell death can be counteracted by masking the surfactant 
bilayer using layer-by-layer (LBL) assembly (Figure 1.5).  
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Figure 1.5:  Cartoon showing the first step of layer-by-layer coating.  Gold nanorods, initially 
covered with a bilayer of positively charged CTAB molecules (white pegs) are exposed to a 
solutions of oppositely charged polymer (poly(styrene sulfonate), PSS (blue)).  Three layers of 
polymers will render the nanorods anionic in aqueous solution, to mask the surfactant bilayer, 
and reduce potential toxicity. 
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1.5 Thesis Overview 
 The work described in this thesis is focused on the use of gold nanorods in chemical 
sensing, biomedical applications and their effects on cardiac fibroblasts in tissue culture.  In 
Chapter 2 a generalized procedure for silica coating of gold nanoparticles of different shapes, 
sizes and surface charge by a simple modified Stöber process is described.  The goal of this work 
is to form functional plasmonic particles for chemical sensing and biomedical applications.  
Chapter 3 describes our investigation of the dependence of SERS enhancement factors of 4-
MBA on surface coverage and aggregation state of gold nanocubes.  Here we use a 
nanoparticle—planar substrate sandwich structure in which varying amounts of gold nanocubes 
were immobilized on SAMs of 4-mercaptobenzoic acid (4-MBA) on sputtered gold slides in 
order to maximize SERS signal.  Optimization of this chip like sensor could lead to the basis of 
Raman sensor for biomedical assays. 
 The remaining 5 chapters in this work describe the use of gold nanorods in collagen 
tissue constructs.  We have used studied the use of our long gold nanorods as a point sensor for 
the tracking of cell-mediated deformation of a 2-D collagen thin film and their effects in 3-D cell 
culture.  Chapter 4 details the development of a method used to understand the mechanism of 
mechanotransduction.  We have developed a novel optical measurement technique, which 
combines the light elastically scattered from gold nanorods with digital image analysis to track 
local deformations that occur in vitro between cells, in real time, under darkfield optical 
microscopy.  While attempting to apply this technique to 3-D tissue constructs it was found that 
gold nanorods have dramatic effects on the ability of cardiac fibroblasts to remodel their 
environment.  Chapter 5 describes our findings that polyelectrolyte coated gold naorods can 
substantially alter the matrix-remodeling behavior of cardiac fibroblasts by interfering with the 
16 
transition of these cells into myofibroblasts, highly contractile cells which produce collagen and 
other extracellular matrix proteins as part of a normal wound healing response.  In an attempt to 
completely understand the mechanism behind how our nanoparticles interfere with cardiac 
matrix remodeling we studied the adsorption of cellular proteins to polyelectrolyte-
functionalized gold nanorods (chapter 6) and their effects on the self-assembly and mechanics of 
type I collagen gels (chapter 7).  It was found in Chapter 6 that the particles were binding 
proteins on the surface of the nanomaterials that can modulate the matrix remodeling behavior of 
fibroblasts.  Chapter 7 describes the findings that the polyanion-terminated nanorods 
significantly reduced the lag (nucleation) phase of collagen self-assembly and significantly 
increased the dynamic shear modulus of the polymerized gels, whereas polycation-terminated 
gold nanorods had no effect on the mechanical properties of the collagen.  Chapter 8 details the 
interaction of glycosaminoglycan-functionalized gold nanorods with type I collagen. This was an 
attempt to reduce the effects our nanorods had on cell-mediated collagen remodeling; however, it 
was found that they also inhibited cell-mediated gel contraction in 3D culture without 
compromising cell viability.  Chapters 5-8 not only detail a mechanism for how gold nanorods 
interfere with cell-mediated matrix remodeling in 3-D tissue culture, but show how they can be 
used as a therapeutic agent for the regulation of cardiac fibrosis.   
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Chapter 2 
 
Silica Coating of Gold Nanoparticles of Different Shapes and Sizes 
 
2.1 Introduction 
 The plasmonic properties of metallic nanoparticles leads to a host of applications such as 
chemical and bio-sensing,1 surface enhanced Raman scattering (SERS),2 bio-imaging using 
elastic light scattering3 and photo-thermal therapies.4 Most of these applications require a surface 
modification step. Biological applications require the particles to be stable under physiological 
conditions of pH and high salt concentrations. Additionally, for bio-imaging and targeting, the 
particles need to be modified with different bio-markers and agents to enhance the specificity of 
nanoparticle binding to the cells/tissue/organ of interest. To this end, polymer and silica coatings 
of nanoparticles offer versatility such as buffer stability, biocompatibility and ease of 
bioconjugation, and hence are attractive surface modification strategies for “bare” nanoparticles.5 
 Silica coating of metallic nanoparticles has long been investigated and there are continuing 
attempts to improve the process.6-8 Broadly, the silica coating of metallic nanoparticles can be 
classified into three groups: 1) attaching silane coupling agents such as mercapto- or amino-
silanes followed by slow growth of a silica shell via addition of sodium silicate;6 2) 
microemulsion techniques wherein nanoparticles trapped in the aqueous pool are coated by slow 
hydrolysis and condensation of tetraethylorthosilicate (TEOS);7 3) the Stöber method for rapid 
hydrolysis and condensation of TEOS in alcohol solution.8,9 Each method has its own 
advantages. The microemulsion method can efficiently encapsulate aqueous metallic 
nanoparticles < 20 nm size. The method involving attachment of silane coupling agents and 
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further growth of a thin silica shell has been a popular route to coat metallic nanoparticles with 
silica and was first developed by Mulvaney and co-workers.6 This process usually takes 24 hrs to 
a few days depending on the thickness of the silica layer desired. 
 The Stöber process offers a rapid and easy way to either form silica particles or coat 
different particles with silica by a seeded method.8 To achieve this, the particles first need to be 
transferred to ethanol/propanol. This is easy if the particles already have a thin coat of silica as 
achieved by the Mulvaney method,6 but this protocol is time consuming (24 hrs to 5 days) and 
hence the overall utility is reduced. Graf et al overcome this by first coating the different 
cationic/anionic particles of different sizes with polyvinylpyrrolidone (PVP).8b,c This helps to 
transfer the particles to ethanol where the seeded Stöber method can be used to grow thick silica 
shells.8b,c Liz-Marzan and co-workers have used this method to coat cetyltrimethylammonium 
bromide (CTAB) stabilized gold nanorods, sub-micron gold nanoparticles and gold decahedra.8d-f 
 Xia and co-workers have used the Stöber method to directly coat commercial suspensions 
of either gold or polystyrene particles, or silver nanowires, without any pre-coating steps.9a-c  
This was achieved by applying the Stöber procedure to a dispersion of 1:4 aqueous particles: 
propanol.9a-c Mine et al coated citrate stabilized gold nanoparticles with silica by the seeded 
polymerization technique based on Stöber method.9d Liu et al also used a direct silica coating 
procedure for citrate-stabilized gold nanoparticles by simply dispersing the particles in 
isopropanol and proceeding with the Stöber process.5d,9e Wang et al extensively purified gold 
nanorods, subsequently raised the pH of the solution and added TEOS for silica coating to 
achieve a ~ 9 nm thick silica coating.9f Gorelikov and Matsuura followed a similar procedure to 
produce 15 nm thick mesoporous silica coating on CTAB-capped gold nanorods with a pore size 
of ~ 4nm.9g Table 2.1 lists the various literature methods. 
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Table 2.1. Literature methods for Stöber or modified Stöber method for silica coating of metallic 
nanoparticles. 
CORRES- 
PONDING 
AUTHOR 
[REF] 
NANOPARTICLE 
TYPE 
NANO-
PARTICLE 
SIZE (NM) 
SURFACE 
FUNCTIONALITY 
INITIAL 
CHARGE 
COATING 
TIME 
SILICA 
SHELL 
THICKNESS 
(NM) 
COATING 
METHOD 
Mulvaney 
[6a,b] 
Gold 
Nanoparticles  
15 Initial: citrate; 
Intermediate: thin 
silica shell 
Anionic 24 h 2 - 80 Two- step 
Murphy 
[6e,f] 
Gold nanorods, 
Silver nanowires 
200 nm, 14 
µm 
CTAB Cationic 16 h 10-150 Two-step 
Graf [8b,c] Gold & Silver 
nanoparticles, 
boehmite rods, 
gibbsite platelets, 
polystyrene 
colloids, 
maghemite 
particles, 
CdSe/ZnS 
Quantum dots 
(QDs) 
4 - 800 Initial: citrate, 
PVP , gum Arabic, 
sulfate. 
Intermediate: PVP 
Cationic & 
Anionic 
PVP coating: 
24h; Further 
silica 
coating: 12-
18 h; Total 
time = 36-42 
h 
Few nm to 
few 100s of 
nm 
Two-step 
Liz-Marzan 
[8d-f] 
Gold nanorods, 
sub-micron sized 
gold nanoparticles, 
gold decahedra 
Aspect ratio 
~ 4 (52 nm 
long; 13 nm 
thick) 
nanorod s to 
sub- micron 
size spheres 
Initial: CTAB; 
Intermediate: 
Polystyrene 
sulfonate, 
poly(allylami ne 
hydrochlorid e), 
PVP 
Cationic Polyelec 
trolyte 
coating: 3-6 
hrs; PVP 
coating: 12h; 
Silica 
coating: 2-24 
h 
10-60 Multi-step 
Konno [9d] Gold nanoparticles 15 Citrate Anionic Unknown 30-90 One step 
Xia [9a-c] Gold 
nanoparticles, 
Polystyrene beads, 
iron- oxide 
particles, silver 
nanowires 
50 nm, 0.1-1 
µm 
Unknown, PVP Unknown 1-3 h 2-100 One step 
Han [5d, 9e] Gold nanoparticles 50 Citrate Anionic 48 h 35-90 One-step; 
multiple 
addition 
steps for 
TEOS 
Ma [9f] Gold nanorods Length ~ 70 
nm, thicknes 
s ~ 35 nm 
CTAB Cationic 24 h 9 One step in 
aqueous 
medium 
Matsuura 
[9g] 
Gold nanorods, 
CdSe/ZnS QDs 
Length ~ 35 
nm, thicknes 
s ~ 10 nm. 
CTAB Cationic 10 h – 
Several days 
15 One step in 
aqueous 
medium 
Gole  
[this work] 
Gold nanorods, 
nanocubes, 
nanospheres, 
triangles and 
hexagons, silver 
nanoparticles 
20-400 CTAB, citrate, 4- 
MBA 
Cationic, 
Anionic 
5 h 13-216 One step in 
ethanol 
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 Surprisingly, to date, the one step rapid silica coating method developed by Xia and co-
workers has not been used to coat anisotropic gold nanoparticles, especially gold nanorods. On 
the other hand, the method developed by Graf and co-workers (multiple polymer coating prior to 
using Stöber method),8b,c has been used widely by Liz-Marzan and others8d-f to coat short gold 
nanorods and some other shapes. This method involves multiple polymer coating and increased 
time scales and applicable to lower concentrations of the nanoparticles. The margin of error 
increases due to the introduction of multiple steps. Our initial attempts to use this procedure 
resulted in aggregation of the particles and a lower reproducibility. Hence in order to coat gold 
nanoparticles of different shapes and sizes, with higher concentration of the particles, lower time 
scales, reduced number of steps, ease of purification and higher reproducibility, we have used the 
direct coating approach developed by Xia and co-workers.9a-c Gold nanoparticles of different 
shapes (spheres, nanorods, cubes, and other shapes) different sizes (18 nm to 400 nm) and 
different surface bound molecules (positive: CTAB, negative: citrate and 4-mercaptobenzoic 
acid, MBA) were used for silica coating. The coating thickness was controlled by varying the 
TEOS concentration as observed by others. The particles were characterized by UV-vis, zeta 
potential and light-scattering measurements, and transmission electron microscopy (TEM). A 
Raman tag (4-mercaptobenzoic acid, MBA) was attached to the 40 nm gold nanoparticles prior 
to silica coating, which opens possibility for particle tracking by SERS, by monitoring the 
Raman vibrations of MBA. Generally, this procedure achieves silica coating at shorter time 
scales (within ~ 5 h), is applicable to a wide range of sizes (18 nm - 500 nm), shapes (sphere, 
rods, etc.), particle type (gold or silver), surface molecule/charge (CTAB : positive or citrate: 
negative). The ability to include a Raman tags prior to silica coating, makes our process an 
attractive approach to form silica-coated functional plasmonic particles for different applications. 
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2.2 Experimental Section 
2.2.1 Materials: Chloroauric acid (HAuCl4 • 3H2O), trisodium citrate, sodium borohydride 
(NaBH4), silver nitrate and ascorbic acid, were obtained from Aldrich and used as 
received. Hexadecyltrimethylammonium bromide (CTAB), Sigma Ultra, 99% was obtained from 
Sigma chemicals and used without further purification. MBA was obtained from TCI America 
and used as received. All glassware was cleaned by aqua-regia (3:1 v/v hydrochloric: nitric acid) 
and water prior to use. De-ionized (DI) water (Resistivity = 18.2 mΩ) was used for all the 
experiments. 
2.2.2 Instrumentation: UV-vis spectroscopy was performed on a Varian model Cary 500 Scan 
UV-Vis- NIR spectrophotometer. Zeta potential and light scattering measurements were 
performed on a Brookhaven Zeta PALS instrument. Transmission electron microscopy (TEM) 
measurements were performed on a Hitachi H-8000 TEM instrument operating at an accelerating 
voltage of 200 kV. For TEM, samples were prepared by immersing a carbon coated copper grids 
in the nanorod solution for 30 min and removing, draining and air-drying of the grid. Surface 
enhanced Raman scattering measurements were performed on 1 mL of as prepared purified 
aqueous samples held in a glass vial and measured on a bench top DeltaNu Raman spectrometer 
with a 785 nm laser. Darkfield light scattering of the nanoparticles was performed by placing a 
100 µL aqueous nanorod solution on a glass slide and imaging by a Nikon Eclipse model 
ME600L microscope equipped with bright field, dark field, and fluorescent imaging capabilities. 
The quantitation of gold content in the gold nanoparticles of different shapes prior to silica 
coating was carried out by inductively coupled plasma (ICP) measurements, performed on a 
Varian Vista ICP-AES spectrometer. Twice purified samples of gold nanoparticles were digested 
with aqua regia (nitric acid: hydrochloric acid; 1: 0.5 v/v) overnight. The gold concentration 
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(mg/L) was determined by comparing the atomic emission peaks with freshly prepared gold 
standards of different concentrations. 
2.2.3 Nanoparticle synthesis: Different size and shapes of gold nanoparticles were synthesized 
using previous published protocols.10 40 nm gold nanospheres10b,c long gold nanorods of aspect 
ratio20,10b short gold nanorods (aspect ratios 1 - 4.3) were prepared by our seed-mediated 
procedures.10a-e Secondary shapes such as triangles and hexagons are generally synthesized as a 
side product in the 40 nm gold nanosphere solutions and have been used for silica coating. 
Gold nanocubes of edge length 48 ± 3 nm were prepared according to a modified protocol.10f 
The seed particles were prepared using a 7.75 mL growth solution containing 0.1 M CTAB and 
3.23 x 10-4 M HAuCl4. To this growth solution 600 µL of an ice cold 10 mM NaBH4 solution 
was added. The resulting solution was stirred for 2 minutes and allowed to sit for one hour before 
use. The seed solution was diluted by a factor of 10 using DI water. For cube synthesis, growth 
solutions were prepared, containing 4 mL DI water, 800 µL 0.1 M CTAB, and 100 µL 0.01 M 
HAuCl4. 600 µL of 0.1 M ascorbic acid was then added to the growth solution and mixed 
thoroughly turning the solution colorless. Next 2.5 µL of the diluted seed solution was added to 
the reaction vessel and the solution was allowed to sit overnight. Cube solutions were purified 
using two rounds of centrifugation at 10,000 rpm for 10 minutes each. 
 18 nm citrate stabilized gold nanoparticles were synthesized by the Frens method of adding 
10 mL 1% sodium citrate solution to 100 mL boiling 2.5 x 10-4 M aqueous gold chloride 
solution10b and citrate stabilized silver nanoparticles (size ~ 50-80 nm) were synthesized by the 
Lee and Meisel method.10g 
 Attachment of Raman Tags: To a 10 mL solution of purified 40 nm CTAB capped gold 
nanoparticles, 0.1 mL of a 10-2 M ethanolic solution of MBA was added and allowed to sit for a 
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period of 2 h prior to silica coating. No additional purification was done after MBA-attachment. 
MBA molecules bind to the gold nanoparticle surface via the sulfur. 
2.2.4 Silica coating: A modified Stöber procedure, similar to that adopted by Xia and co-
workers,9a-c has been used to form uniform silica coatings on different size and shaped 
nanoparticles. The as-prepared particles were purified twice by centrifugation (long rods at 8000 
rpm for 8 minutes; short rods and nanospheres at 14000 rpm for 10 minutes; nanocubes at 10000 
rpm for 10 minutes). Post purification, the particles dispersed in DI water could be coated with 
silica at the as-synthesized nanoparticles concentrations (long gold nanorods = 0.9 x 10-11 M; 
short gold nanorods = 0.3 x 10-10 M, gold nanospheres = 0.5 x 10-10 M, gold nanocubes = 0.6 x 
10-11 M) or after concentrating the particles 2-10 times prior to silica coating (gold nanospheres: 
3 times, long gold nanorods: 8 times, short gold nanorods: 10 times, gold nanocubes: 5 times). It 
is important to remember that the total number of centrifugation and re-dispersion cycles prior to 
silica coating should be kept to two in order to avoid aggregation and “group coating” of the 
nanoparticles. To an aqueous 0.5 mL of nanoparticle solution, 25 mL of ethanol was added under 
stirring. Subsequently, 1 mL each of DI water and aqueous ammonium hydroxide (29.5 % 
solution) solutions were respectively added. After 10 min stirring, different amounts of TEOS 
(0.1 mM to 22 mM) were added under vigorous stirring. The stirring was stopped after 5 min of 
TEOS addition and the solutions were left undisturbed for 5 hrs. After this, the particles were 
purified (twice by ethanol and twice by water) by centrifugation and re-suspension and finally 
dispersed in DI water for further studies. 
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2.3 Results and Discussion 
 The Stöber process for silica coating is an attractive method to coat metallic nanoparticles 
of sizes > 20 nm. The procedure requires the particles to be dispersed in ethanol/propanol, which 
can be done by different methods. Table 2.1 lists the different examples in literature for the 
Stöber or modified Stöber method for silica coating of metallic nanoparticles. 
Most of these methods employ an intermediate coating (PVP or thin silica shell) before the 
particles can be dispersed into ethanol/propanol. Direct silica coating has also been developed 
but only spherical and some rod shapes have been studied. In this report we demonstrate a 
universal method for uniform silica coating with variable shell thicknesses, applicable to 
different sizes (20 nm to 400 nm) and shapes (sphere, short and long nanorod, cubes, hexagon 
and triangles) of gold and for spherical silver nanoparticles, with different surface functionality 
and charge (CTAB or citrate). The option of including a Raman tag prior to silica coating 
enhances the utility of this procedure for bio-imaging and bio-sensing applications. 
 Figure 2.1 shows the TEM images of long gold nanorods (aspect ratio ~ 20) coated with 
silica at different concentrations of TEOS (0.1 mM to ~ 23 mM). The concentration of the long 
gold nanorods used in all the cases was in the range of 2 x 10-11 M to 7 x 10-11 M (as determined 
by ICP measurements). A clear increase in the silica coating thickness can be seen as TEOS 
concentration is increased (from 13 nm to 216 nm). The nanorods are individually coated with 
silica instead of a “group- coating”. At lower TEOS concentrations (~0.1-1 mM), non-uniform 
and “bumpy” silica coatings are evident (Fig. 2.1 A-C). For very low concentrations of TEOS, 
the coating appears to be highly non- uniform (Fig. 2.1A). At higher concentration of TEOS (> 
1mM), a large number of free silica particles can be seen, which happens due to the uncontrolled 
nature of hydrolysis of TEOS. We also find that it was difficult to achieve silica coatings at 
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lower concentrations of TEOS (< 0.1 mM). 
 The relation between the amount of TEOS added and the thickness of the silica shell 
obtained upon coating for long gold nanorods is shown in Figure 2.2A. The data was obtained by 
performing measurements on different TEM images obtained as in Figure 2.1. The shell 
thickness was obtained by subtracting the thickness of gold nanorods. A clear increase in the 
silica shell thickness as a function of TEOS concentration can be achieved. For 0.1 mM TEOS 
concentration, a silica shell thickness of ca 13 nm was obtained. There is an initial steady growth 
of silica shell thickness as a function of TEOS concentration (~ 4.3 mM) which eventually 
stabilizes indicating no additional increase in the coating thickness with increasing TEOS 
concentration. A maximum silica shell thickness of 216 ± 7 nm was obtained for TEOS 
concentrations of 13.6 mM and above. 
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Figure 2.1: TEM images of long gold nanorods (aspect ratio ~ 20, concentration = 3 x 10-11M) 
coated with silica, as a function of varying TEOS concentration. TEOS concentrations are: A = 
0.1 mM, B = 0.5 mM, C = 1 mM, D = 4.5 mM, E = 9 mM, F = 13.6 mM, G = 18.8 mM, H = 
22.7 mM. 
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 Figure 2.2B shows the transverse plasmon band shifts for gold nanorods (aspect ratio ~ 20) 
as a function of the silica shell thickness, which as mentioned earlier, is due to the variations in 
the TEOS concentration. The longitudinal plasmon band lies around 1450 nm and is difficult to 
study for plasmon shifts due to increased scattering and higher interference due to water with 
increasing slica thickness. The as-prepared gold nanorods show a plasmon peak at ca 500 nm. 
This peak red-shifts to 504 nm with the first coating of 13 nm thick silica shell (curve 1, TEOS 
concentration = 0.1 mM). This indicates successful surface modification and coating of the rods. 
As the coating thickness increases, (0.5 mM – 22.7 mM TEOS) the plasmon peak shifts further 
(curve 2 – 7, Figure 2.2B) to a maximum of 516 nm at a TEOS concentration of 13.6 mM (curve 
6, Figure 2.2B), after which it becomes difficult to estimate the peak positions due to the weak 
plasmon band riding over a slope (curve 7, figure 2.2B). The plasmon band is sensitive to small 
changes in the local dielectric function surrounding the nanoparticles.11 Upon silica coating the 
local refractive index of the rods changes and hence such red shifts are observed by us here and 
also by others before.8d  Interestingly, Liz-Marzan and co-workers were unable to detect changes 
in the transverse plasmon band. On the other hand, Ma and co-workers did observe small shifts 
in the transverse plasmon band to which our results seem to agree.9f Additionally, our previous 
work on silica coating of silver nanowires does show shifts in the transverse plasmon band as a 
function of coating thickness.6f 
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Figure 2.2: A) Thickness of silica coating on long gold nanorods (aspect ratio ~ 20) measured 
by TEM with varying TEOS concentration and B) corresponding UV-vis spectra (the last TEOS 
concentration used, curve 7 = 18.8 mM). C) Zeta potential variation as a function of silica shell 
thickness for long gold nanorods (aspect ratio = 20). The inset shows the hydrodynamic size of 
the silica coated long rods as a function of increasing TEOS concentration. The solid lines in 
both the cases are an aid to the eye. 
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 Figure 2.2C shows the zeta potential variation of the long gold nanorods as a function of 
silica shell thickness. The as-prepared gold nanorods have a positive zeta potential due to a  
bilayer of CTAB. Upon silica coating, the net charge on the surface of the particles becomes 
progressively negative. The hydrodynamic size of the nanorods also follows a similar trend: a 
steady increase from ~ 40 nm (as- prepared nanorods) to ~ 229 nm (TEOS = 18 mM) (as seen in 
the inset of figure 2.2C). 
 Additionally, we have also studied the gold nanorods before and after thick silica coating 
(silica shell thickness ~ 200 nm) by darkfield light scattering. Bright yellowish-green light is 
scattered from these samples (Figure 3 A, B) due to the elastic light scattering of gold 
nanorods.3b,e  It is important to note that even though the gold nanorods are coated with a silica 
shell thickness of ~ 200 nm, they do show light scattering (Figure 2.3B) albeit less intense, but 
that has color (yellowish-green) comparable as that of bare, uncoated gold nanorods (Figure 
2.3A). We believe that any possible small red shifts in the scattering color due to silica coating 
are difficult to visualize by an ordinary eye. A spectroscopic analysis of such scattering could 
possibly reveal such shifts, which unfortunately is unavailable on the microscope used for this 
study. Nonetheless, the presence of scattering indicates that such particles are not-only 
biocompatible (due to silica shell) but also can be used for imaging applications. Control 
experiments with plain silica particles in the absence of gold nanorods failed to show such 
brilliant scattering. 
We have also studied the silica coating of short gold nanorods (0.3 nM in particles, aspect ratio 1 
to 4.3) at a constant TEOS concentration (0.5 mM). Fig 2.4 A-E shows the respective TEM 
images of these particles. Particles with aspect ratios of 1 ± 0.3 (Figure 4A), 2.3 ± 0.6 (Figure 
4B), 2.8 ± 0.5 (Figure 4C), 3.7 ± 0.7 (Figure 4D) and 4.3 ± 0.6 (Figure 4E) were used for this 
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study. A uniform silica coating can be clearly seen in all the cases with substantially small 
amount of “group-coating”. It is important to note that such highly concentrated particles (0.3 
nM) do not aggregate in ethanol and were found to be quite stable during the process of silica 
coating. Additionally it is important to purify the gold nanorods twice at 14000 RPM for 10 
minutes to remove excess CTAB prior to silica coating, which otherwise leads to aggregation or 
group coating. Figure 2.4F is a representative UV-vis spectrum of 3.7 ± 0.7 aspect ratio gold 
nanorods before (curve 1) and after (curve 2) silica coating. A clear red shift in the transverse 
and longitudinal plasmon bands can be seen, as seen by others.8d The transverse plasmon band 
shifts from 509 nm to 511 nm (a ~ 2nm red shift) after silica coating. Whereas a larger red shift 
is observed for the longitudinal plasmon band (719 nm to 740 nm = 21 nm red shift) upon silica 
coating. A ten-fold larger shift for the longitudinal plasmon band indicates its higher sensitivity 
to the local environmental changes compared to that of the transverse band. 
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Figure 2.3: Darkfield light scattering images of as-prepared (aspect ratio ~ 20) gold nanorods 
(A) before and (B) after ~ 200 nm thick silica coating (TEOS concentration = 18.8 mM). The 
yellow-green scattering is visible for both the cases. (See text for details). 
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Figure 2.4: Silica coated short gold nanorods of different aspect ratios ranging from A) 1 ± 0.3; 
B) 2.3 ± 0.6; C) 2.8 ± 0.5; D) 3.7 ± 0.7 and E) 4.3 ± 0.6, F) UV-vis spectra of 3.7 ± 0.7 aspect 
ratio gold nanorods before (curve 1) and after silica coating (curve 2). Concentration of TEOS 
used for silica coating in each case = 0.5 mM. The concentration of nanorods used in all the 
cases = 0.3 nM (see text for details). 
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 To further demonstrate the generality of the silica coating approach, we have included 
other shapes such as gold nanocubes, triangles and hexagons. Silica coating of these shapes was 
carried out as was done for the gold nanorods. The as-prepared concentration of gold nanocubes 
(by ICP) was 0.6 x 10-11 M. For silica coating, the particles were concentrated 5 times (final 
concentration = 3 x 10-11 M). Fig 5A and B shows the TEM of silica coated gold nanocubes at 
low and high magnifications respectively. A clear smooth silica coating can be observed. TEOS 
concentrations used are 0.5 mM (fig 2.5A) and 1 mM (Figure 2.5B). Silica shell thickness 
increases from ~ 16 nm (0.5 mM TEOS) to ca 45 nm (1 mM TEOS). Under similar lines, silica 
coating of triangles and hexagons can also be seen (Figure 2.5C and D respectively). It is 
interesting to note that the silica coating takes the shape of the particle. This would be an 
interesting way to develop different size and shaped hollow silica particles after removing the 
metal core and will be reported elsewhere. 
 Finally we have also demonstrated successful silica coating of nanospheres. Different 
surface modified nanoparticles such as 18 nm citrate capped gold nanoparticles (Frens 
method)10b; 50-80 nm diameter citrate capped silver nanoparticles (Lee and Meisel method),10f ~ 
40 nm CTAB capped gold nanoparticles (our seed mediated method),10b,c and 4-MBA capped 40 
nm gold nanoparticles (obtained by place-exchange of CTAB on the gold nanoparticles) have 
been studied. The concentration of TEOS in each case was 0.5 mM. The concentration of the 
particles used for this study was ~ 0.1 -0.3 nM. TEM images shown in Figure 2.6 correspond to 
silica coated 18 nm gold nanoparticles (Figure 2.6A), silver nanoparticles (Figure 2.6B) and 40 
nm CTAB capped gold nanoparticles (Figure 2.6C). A TEM image of MBA capped gold 
nanoparticles has been excluded for brevity. A SERS spectrum for MBA molecules attached to 
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gold nanoparticles is shown as Figure 2.6D. The two sharp prominent features at ca 1077 cm-1 
and 1588 cm-1 correspond to the ring breathing modes for the MBA molecule.11 In the absence of 
silver nanoparticles MBA molecules fail to show such strong Raman scattering. Hence such 
silica coated SERS active particles hold potential for tracking applications. 
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Figure 2.5: TEM images for different shapes of gold nanoparticles after silica coating A) cubes 
(Concentration = 3 x 10-11 M), B) single cube at higher magnification, C) triangle and D) 
hexagon. TEOS concentration for A, C and D = 0.5 mM and that for B = 1 mM. 
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Figure 2.6: Silica coated A) 18 nm citrate capped gold nanoparticles, B) 4-MBA coated silver 
nanoparticles, and C) 4-MBA-coated 40 nm gold nanoparticles and D) its corresponding SERS 
spectra. Concentration of the spheres in all the cases was in the range ~ 0.1 -0.3 nM. 
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2.4 Conclusion 
 A simple, versatile and general methodology has been developed to silica-coat gold 
nanoparticles of different shapes and sizes such as long gold nanorods (aspect ratio ~ 20), short 
gold nanorods (aspect ratio ~ 1- 4.3), gold nanocubes, triangles, hexagons and spheres. The silica 
coating thickness for long gold nanorods has been shown to depend on the amount of TEOS 
added. The plasmonic properties of gold nanorods are retained even at thicker silica coatings. 
The generality of the procedure has been demonstrated not only by different shapes and sizes of 
the particles but also by extending the protocol for positively as well as negatively charged 
particles. Additionally, silver nanoparticles can also be coated with silica using this procedure. 
The added advantage over other protocols is the direct approach involved that avoids multiple 
coating steps. The fast time scales, generality of the approach, and the ability to include a Raman 
probe prior to silica coatings, with the retention of the plasmonic properties of these particles, 
makes our approach useful for developing silica- coated bio-compatible, plasmonic nanoparticles 
useful for biological applications. 
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Chapter 3 
 
Surface-Coverage Dependence of Surface-Enhanced Raman Scattering from Gold 
Nanocubes on Self-Assembled Monolayers of Analyte  
 
3.1 Introduction 
Surface enhanced Raman scattering (SERS) spectroscopy is a powerful technique to 
obtain vibrational information about molecules on or near a nanoscale metallic surface.1  Since 
the introduction of SERS on roughened silver electrodes in 1977, 2,3 there has been a great deal 
of research to maximize the Raman signals from adsorbates on gold and silver substrates.  
Recent developments in the controlled synthesis of gold and silver nanomaterials of different 
shapes have led to a renewed interest in SERS.4-18  For gold and silver, decreasing particle size 
below the electron mean free path (~10-100 nm) leads to an intense absorption, in the visible—
near-infrared region of the electromagnetic spectrum, known as a plasmon resonance.12  This 
plasmon resonance produces a large electromagnetic field that extends outward from the 
nanoparticle surface up to 10 nm, or farther, depending on particle size.  The plasmon frequency 
can be tuned by changing the size, shape, and aggregation state of the nanoparticles.12,13  As 
Raman scattering intensity is proportional to the fourth power of the local electric field, 
molecules within ~10 nm of a nanoscale metal surface can have their Raman-active band 
intensities increase by 6-10 orders of magnitude.1,14,15  Molecules caught in the junctions 
                                                
  * This chapter has been published in the Journal of Physical Chemistry A.  Sisco, P. N.; Murphy, C. J. J. Phys. Chem. A 2009, 113, 3973-3978. 
(Reproduced by permission of The American Chemical Society and co-authors) 
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between nanoparticles have even larger SERS signal enhancements, because the spatially 
coincident local electric fields provide “hot spots” for SERS.16  
Nanoparticles with corners and sharp tips are of significant interest as SERS substrates.17-
19 Local electric field enhancements are seen for all types of noble metal nanoparticles, but even 
greater local field enhancements are observed at sharp surface features, like the corners of gold 
nanocubes, where the curvature radius is much smaller than the size of the nanoparticle.20  This 
phenomenon is known as the “lightning rod” effect on surface enhancement.20,21  This effect has 
led many researchers to use gold and silver nanomaterials of different morphologies as SERS 
substrates.  The Moskovits lab has studied SERS on both aligned silver nanowire rafts22 and 
metal-silica hybrid nanostructures.23  The El-Sayed group has investigated the use of both 
unaggregated24 and aggregated25 gold nanorods as SERS substrates.  More recently the El-Sayed 
group has shown that human oral cancer cells can align antibody-derivatized gold nanorods on 
the cell surface, and this nanorod alignment on the cell surface leads to a SERS fingerprint 
unique to the cancer cells.26  The Halas group has shown that large enhancement factors of 109-
1010, compared to normal Raman spectra, can be observed for 4-mercaptoaniline using gold 
nanoshells.27  Many complex SERS substrates have also been prepared by the van Duyne group 
using nanosphere lithography for the quantitative detection of analytes such as glucose and 
biowarfare agents.1 
  One of the biggest challenges facing SERS on colloidal nanoparticle substrates is 
reproducibility.  It is essential to know both the number of nanoparticles in solution as well as the 
number of molecules sampled during the experiment for analyte quantitation and calculation of 
SERS enhancement factors.  This can be difficult for colloidal nanoparticles because the number 
of molecules in nanoparticle junctions, which could contribute the majority of the signal, is 
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typically unknown. SERS measurements on self-assembled monolayers (SAMs) of the target 
analyte on planar gold substrates allows for the SAMs to be deposited on a smooth gold surface 
and allows for the number of molecules sampled to be well known; but the SERS signals 
obtained from planar substrates are weak.17 
 Previous reports from this laboratory have demonstrated a colloidal chemistry approach 
to improve SERS for analytes adsorbed to smooth gold substrates.1,17,28   This was based on a 
nanoparticle—planar substrate sandwich structure in which gold nanoparticles of various shapes 
and sizes were immobilized on SAMs of 4-mercaptobenzoic acid (4-MBA) on sputtered gold 
slides. The SERS enhancements seen with this sandwich geometry originate from the plasmon 
coupling between the localized surface plasmon of the nanoparticles and the surface plasmon of 
the gold substrate, creating a large local electromagnetic field for the molecules between the 
planar substrate and the nanoparticles.17  We found that the largest Raman signal enhancement 
were for gold nanocubes (109-fold increase in signal compared to normal Raman of a solution of 
4-MBA), compared to spheres, rods, and other shapes, for which 107-108 signal enhancements 
were observed.17    In our earlier report,  the focus was on the effect of particle shape on SERS 
signals, in the condition of “no” junctions between the nanoparticles on the SAM.17  In this 
report, we investigate the effects of both an increase in surface coverage as well as an increase in 
aggregation of gold nanocubes on the enhancement of the Raman signal for 4-MBA in this 
sandwich architecture.   Our hypothesis was that as aggregation of nanocubes increased, SERS 
signal intensities from the underlying SAM would increase more than simple surface coverages 
would predict.   
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3.2 Experimental Section 
3.2.1  Materials.  Chloroauric acid (HAuCl4.3H2O), sodium borohydride (NaBH4), ascorbic 
acid, and 4-mercaptobenzoic acid (4-MBA) were obtained from Aldrich. 
Hexadecyltrimethylammonium bromide ( = cetyltrimethylammonium bromide, CTAB) was 
obtained from Sigma as a sigmaUltra pure reagent.  All reagents were used as received.  
Deionized ultra filtered (DIUF) water was obtained from Fisher and used for all procedures.  All 
glassware was cleaned with aqua regia, rinsed thoroughly with DIUF water, and dried prior to 
use. 
3.2.2  Instrumentation. Surface-enhanced Raman spectra were collected using two different 
Jobin Yvon Horiba confocal Raman spectrometers.  The first is equipped with a p-polarized 
632.8 HeNe laser with a 2 µm spot size using the 80x objective and 5 mW power at the sample.  
The second system is equipped with p-polarized 785 laser with a 1 µm spot size using the 100x 
objective and 7 mW power at the sample.  Samples were excited normal to the surface. 
Absorption spectra of nanoparticles in aqueous solution were acquired using a Cary 500 Scan 
UV—vis—NIR spectrometer.  Zeta potential measurements were performed on a Brookhaven 
Zeta PALS instrument.  Scanning electron micrographs were acquired using an FEI Quanta 200 
environmental scanning electron microscope.  It is important to note that the Raman spectra and 
SEM images were acquired on the same sample in approximately the same region in order to 
minimize possible effects from sample heterogeneity.  Transmission electron microscopy was 
performed on a Hitachi H-8000 microscope, and electron diffraction patterns were obtained 
using a JEOL 2100F HRTEM. 
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3.2.3  Nanocube Synthesis.  Gold nanocubes of edge length 47 ± 3 nm were prepared according 
to a modified surfactant-directed seed-mediated approach.29  The seed particles were prepared 
using a 7.75 mL growth solution containing 0.1 M CTAB and 3.23 x 10-4 M HAuCl4.  To this 
growth solution 600 µL of an ice cold 0.01 M NaBH4 solution was added.  The resulting solution 
was stirred for 2 minutes and allowed to sit for one hour before use.  The seed solution was 
diluted by a factor of 10 using DIUF water.  For cube synthesis, growth solutions were prepared 
that contained 4 mL DIUF water, 800 µL 0.1 M CTAB, and 100 uL 0.01 M HAuCl4.  600 µL of 
0.1 M ascorbic acid was then added to the growth solution and mixed thoroughly, turning the 
solution colorless.  Next, 2.5 µL of the diluted seed solution was added to the reaction vessel and 
the solution was allowed to sit overnight.  Nanocube solutions were purified using two rounds of 
centrifugation at 10,000 rpm for 10 minutes each.  The final product was characterized by 
transmission electron microscopy, dynamic light scattering, and zeta potential (effective surface 
charge) analysis.  Average cube size was 47 ± 3 nm, and the positive zeta potential (23.17 ± 2.23 
mV) was consistent with a bilayer of CTAB on the surface, as we have postulated before.28-30 
 
3.2.4  Nanoparticle Immobilization on SAMs.  Gold substrates were prepared by sputtering 10 
nm of chromium, followed by 100 nm of gold, on piranha-cleaned glass microscope slides cut to 
1 cm2.  These slides were immersed in a 1 mM ethanolic solution of 4-MBA for 24 hours to form 
the SAM on the gold surface.17  After 24 h, the slides were rinsed thoroughly with ethanol and 
dried under nitrogen.  A 20 mL solution of gold nanocubes was purified and resuspended in 4 
mL DIUF water.  The gold-coated glass slides containing the SAMs of 4-MBA were immersed 
in 1 mL of the purified cube solution for 30 min, 1 h, 2h, 3 h to electrostaticaly bind the cubes to 
the SAM.  The prepared slides were then rinsed with DIUF water and dried under nitrogen.  
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Under these conditions, the 4-MBA SAM should be deprotonated to allow for electrostatic 
binding of the CTAB-caped gold nanocubes to the SAM surface.17  Longer incubation times lead 
to higher surface coverages. 
 
3.2.5  Surface Coverage and Aggregation Measurements. Nanocube surface coverage was 
calculated by dividing the total number of nanocubes counted in any given SEM field by the area 
of that field.  Surface coverage values are reported as cubes/µm2 and are averaged over three 
SEM micrographs for each incubation time.  Estimates of % aggregation were made using 
ImageJ analysis software, as counting the number of particles per aggregate was difficult by eye 
from the SEM micrographs.   The known average area of a particle was compared to the size of 
SEM-observed aggregates to determine the number of particles present in each aggregate. 
Aggregates were defined as 2 or more particles separated by less than 10 nm.  The percent 
aggregation for each sample was defined as the ratio of the number of nanocubes in aggregates to 
the total number of nanocubes per slide. 
 
3.2.6  Calculation of Enhancement Factor.  Surface enhancement factors (EF) were calculated 
for each of the different nanoparticle shapes using the following expression  
EF= [ISERS]/[IRaman] x [Mbulk]/[Mads] 
where Mbulk is the number of molecules sampled in the bulk, Mads is the number of molecules 
adsorbed and sampled on the SERS-active substrate, ISERS is the intensity of a vibrational mode 
in the surface-enhanced spectrum, and IRaman is the intensity of the same mode in the Raman 
spectrum.  For all spectra, the intensity of the CC ring-breathing mode ( 1075 cm-1) was used to 
calculate EF values.  No Raman spectrum of the 4-MBA SAM without nanocubes was observed; 
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therefore, the spectrum of aqueous 0.1 M 4-MBA was used to normalize the SERS data in the EF 
calculation.  All spectra were normalized for acquisition time. The number of molecules sampled 
in the SERS experiments was determined by calculating the total two-dimensional area or 
“SERS footprint” occupied by the nanoparticles in the illuminated laser spot on the surface.  This 
was approximated by multiplying the number density of nanoparticles (obtained using SEM 
images like those seen in Figure 3.3), the illuminated spot size, and the nanoparticle footprint 
area (from TEM images such as the one in Figure 3.1A) to give the total SERS surface area 
sampled.  This number was multiplied by the bonding density of 4-MBA molecules in a SAM, 
0.5 nmol/cm2, to give the total number of molecules sampled in the SERS experiments.  
3.3 Results and Discussion 
3.3.1  Nanocube Characterization and Immobilization.  Figure 3.1A shows a typical 
transmission electron micrograph of the gold nanocubes used in this study; average particle size 
is 47 ± 3 nm.    Figure 3.1B shows a high-resolution TEM image of a single gold nanocube and 
its corresponding selected-area electron diffraction pattern is shown in Figure 3.1C.   The 
electron diffraction data suggest that the cubes are bounded by the {100} facets of gold, as others 
have observed before.31  Gold cubes of edge lengths 47 ± 3 nm have only one plasmon band at 
~545 nm which does not have significant overlap with either of the laser lines used in the 
subsequent SERS experiments.  
  The gold nanocubes as made bear a bilayer of the structure-directing surfactant CTAB, 
which in turn imparts a high positive effective charge to the particles and leads to the 
trimethylammonium headgroup of CTAB facing the solvent.30,32,33  The 4-MBA SAM displays 
the carboxylic acid group to the solvent, which is deprotonated under our conditions to allow for 
electrostatic immobilization of the nanocubes on the surface (Figure 3.2), as demonstrated 
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previously.28  Increasing incubation times of nanocube solutions with the SAMs led to increased 
surface coverage of the cubes on the SAMs.  Figure 3.3 shows representative SEM images of 
gold nanocubes for the lowest (30-minute incubation time; Figure 3.2A) and highest (3-h 
incubation time; Figure 3.2B) surface coverage and degree of aggregation.  In Figure 3.2A the 
gold nanocubes are distributed on the surface with a density of 5.5 cubes/µm2 and we estimate 
~14% of the cubes aggregated, as we defined in the Experimental Section.  In Figure 3.2B the 
gold nanocubes are distributed on the surface with a density of 22 cubes/µm2 and we estimate 
~51% of the cubes are aggregated.  The average number of nanocubes sampled within the spot 
sizes of the lasers for the 785 nm and 632.8 nm Raman systems range from 4.4 - 17 cubes for the 
785 nm system and 17 - 69 cubes for the 632.8 nm system, depending on surface coverage.  It is 
not possible in the deposition process to separately control surface coverage and degree of 
aggregation; however, we can crudely separate out surface coverage from aggregation state using 
image analysis of the SEM images, as per the Experimental Section. 
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Figure 3.1: A) Transmission electron micrograph of gold nanocubes. Scale bar = 100 nm.  B)  
High- resolution transmission electron micrograph of one of the gold nanocubes used for single-
area electron diffration.  Scale bar = 20 nm.  C)  Representative diffraction pattern showing the 
{100} crystallographic facets of the nanocubes. 
A C 
B 
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Figure 3.2:  Scheme of the SAM-nanocube sandwich geometry used for obtaining SERS spectra 
of 4-MBA on smooth gold substrates.  The circle zoom-in shows a schematic of the CTAB 
bilayer on the nanocube surface.  Laser irradiation at either 633 nm or 785 nm results in SERS 
from the 4-MBA immobilized below the particles.  
 
 
 
 
 
 
 
 
 
 
  
   
4-MBA SAM 
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Figure 3.3: Scanning electron micrographs of A) gold nanocubes electrostaticaly immobilized 
on 4-MBA SAM at 5.5 cubes/µm2 with ~14% aggregation (scale bar = 5µm); B) gold nanocubes 
electrostaticaly immobilized on 4-MBA SAM at 22 cubes/µm2 with ~51% aggregation (scale bar 
= 10 µm). The background is dark gray and the nanocubes are white in this image mode. 
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3.3.2  SERS of 4-MBA SAMs Using Gold Nanocubes at Varying Surface Coverages and 
Aggregation States.    For these experiments two different Raman microscopes were used, with 
laser lines at 632.8 nm or 785 nm.  A set of 5 sample slides were made ranging from a surface 
coverage of 0 to 22 cubes/µm2 and analyzed using a 3 s acquisition time for the 632.8 nm Raman 
system and 120 s for the 785 nm Raman system.  Raman spectra were recorded in triplicate from 
100 areas of each slide and averaged to determine the representative Raman intensity from each 
slide.  The results for each time point are highly reproducible over all areas of each chip for both 
laser lines.  There are no characteristic 4-MBA vibrational signals for the SAM of 4-MBA for 
either laser line without immobilized gold nanoparticles, as we have observed before.17 No 
CTAB Raman lines interfere with the 4-MBA signal, as we have observed before.17  However, as 
the coverage of nanocubes on the surface of the chip is increased, the characteristic vibrational 
modes of 4-MBA begin to appear and increase in intensity (Figures 3.4 and 3.5).  These modes 
include: the stretching associated with the ring breathing modes at 1075 cm-1 and 1581 cm-1, the 
bending of the CH groups on the ring at 1152 cm-1 and 1177 cm-1, and the stretching associated 
with the carboxylate group at 1268 cm-1.  At sufficiently high nanocube coverages, the CH 
bending modes and carboxylate stretching modes are evident (Figures 3.4 and 3.5).   Minor 
differences in the relative peak intensities at the two excitation wavelengths are observed, 
consistent with theoretical calculations of SERS spectra at two different excitation 
wavelengths.34  
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Figure 3.4: Raman spectra taken at 785 nm of the 4-MBA SAM:  A) alone (black line); B) with 
5.5 cubes/µm2 at ~14% aggregation of cubes; C) 8.6 cubes/µm2 at ~42% aggregation of cubes; 
D) 15 cubes/µm2 at ~43% aggregation of cubes; E) 22 cubes/µm2 at ~51% aggregation of cubes. 
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Figure 3.5: Raman spectra taken at 633 nm of of the 4-MBA SAM:  A) alone (black line); B) 
with 5.5 cubes/µm2 at ~14% aggregation of cubes; C) 8.6 cubes/µm2 at ~42% aggregation of 
cubes; D) 15 cubes/µm2 at ~43% aggregation of cubes; E) 22 cubes/µm2 at ~51% aggregation of 
cubes. 
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Figure 3.6: UV-vis-NIR absorption spectra of gold nanocubes: (solid line) before aggregation 
and (dashed line) after aggregation by increasing salt concentration.    
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Aggregation of noble metal nanoparticles in general is known to enhance SERS signals, 
although quantitation of this effect can be difficult to unravel.  The Kneipp group has shown that 
aggregation of gold nanoparticles in solution can lead to enhancement of an analyte’s SERS 
signal by 10 orders of magnitude over isolated gold particles.16 Moskovits et al estimate that 
junctions between supported silver spheres compared to small solution aggregates provide 100-
1000x  SERS signal intensities from molecules in the junction.35  Previously, we have shown that 
SERS enhancement factors are 109 for gold nanocubes in the “0% aggregation state” on a flat 
gold surface, compared to the normal Raman spectrum of 4-MBA in aqueous basic solution 
(although those nanocubes were slightly larger than the ones made here).17   Here, we increase 
the surface coverage of the nanocubes on the analyte SAM in order to start forming junctions 
between the nanocubes in order to increase SERS intensity and enhancement factor – assuming 
that the nanocube-nanocube junctions’ increased electric field could be accessed by molecules 
underneath the nanocubes.   
In solution, aggregation between gold nanocubes does lead to a decrease in the 
absorbance at ~545 nm and the growth of a broad peak centered at ~844 nm (Figure 3.6).  Thus, 
increased nanocube absorbance on the SERS substrates due to aggregation is convoluted into the 
spectral response.  We had expected that if we found that SERS signals increased in a simple 
linear manner with surface coverage, then the amount of molecules sampled would be directly 
proportional to signal, and thus the degree of surface-bound nanocube aggregation is likely 
irrelevant, perhaps because the increased local electric field is concentrated too far above the 
SAM.  If the SERS signals increased exponentially (for example) as a function of surface 
coverage, then we would suspect that the increased nanocube aggregation that accompanies 
increased surface coverage would be responsible for these nonlinear effects.  
62 
 
Figure 3.7A and B show SERS signal intensity vs. surface coverage in cubes/µm2 for the 
two laser lines used, and we indeed find that there is a linear relationship between SERS 
intensity and surface coverage for both 632.8 and 785 nm excitation. We note that in our system, 
not only is the analyte below the nanocubes, as can be seen schematically in Figure 3.2, but the 
nanocubes contain a bilayer of CTAB on the surface which provides a ~2.4 nm spacer between 
the nanocubes and the analyte (although molecules may partition into this bilayer).37  Our data 
support the work of Kall et al, who have calculated that the position of SERS hot spots between 
two particles (assuming no crevices) is concentrated in the middle of the nanoparticles and does 
not appreciably “leak” out to the particle boundaries (although these effects probably depend on 
the absolute particle size as well).36 Excitation of identical samples at 785 nm does provide more 
of a signal boost than excitation at 632.8 nm, likely in part due to the increased absorbance of the 
sample at 785 nm compared to 632.8 nm (Figure 3.6).  Enhancement factors also show this trend.  
The enhancement factors calculated from the data obtained at 785 nm range from 3.1 ± 0.3 x 
1012 to 1.0 ± 0.3 x 1013  but those associated with the data obtained at 632.8 nm range from 7.8 ± 
1.5 x 107 to 4.1 ± 0.4 x 108 (Table 3.1).  The enhancement factors are also higher at 785 nm 
because free 4-MBA has weaker normal Raman signals at this excitation wavelength.  The 
calculated enhancement factors apparently decrease slightly with increasing nanoparticle surface 
coverage, but theses numbers are highly dependent on accurate estimations of molecules 
sampled.   The far more significant parameter is choice of laser wavelength; in our previous 
work at 632.8 nm excitation, gold nanocubes of a slightly different size and lower surface 
coverages gave 109-fold enhancements; but here, 785 nm excitation adds orders of magnitude to 
the enhancement factors.  Beyond this, mechanisms to improve SERS signals of molecules in our 
SAM geometry might include (i) using particles with sharper and perhaps more unusually shaped 
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tips to funnel the local electric fields to the SAM; (ii) increasing the size of nanocubes so that 
they absorb more of the incident light.   
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Figure 3.7: Dependence of Raman signal intensity on nanocube surface coverage A) Nanocube 
coverage vs. intensity for the 785 nm data (linear fit shown); B) nanocube coverage vs. intensity 
for the 632.8 nm data (linear fit shown) 
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Table 3.1: Calculated Surface Enhancement Factors (EF) for 4-MBA SAMs on Gold Substrates 
with Immobilized Gold Nanocubes. 
Surface Coverage 
(cubes/µm2) 
Enhancement Factor (785 nm 
excitation) 
Enhancement Factor (633 nm 
excitation) 
14 ± 1 1.0 ± 0.3 x 1013 4.1 ± 0.4 x 108 
42 ± 1 7.0  ± 1.9 x 1012 2.2 ± 0.7 x 108 
43 ± 2 5.5  ± 0.8 x 1012 1.1 ± 0.3 x 108 
51 ± 3 3.1  ± 0.3 x 1012 7.8 ± 1.5 x 107 
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3.4 Conclusion 
           This report offers a colloidal chemistry approach to maximize signal from SERS analytes 
adsorbed to planar substrates.  Gold nanocubes were immobilized on SAMs of the Raman active 
molecule 4-MBA on smooth gold substrates by electrostatic interactions.  This creates a 
sandwich architecture in which the localized surface plasmon band of the gold nanocubes 
couples with the surface plasmon of the gold substrate creating a large localized electromagnetic 
field enhancement.  This electromagnetic field leads to an enhancement of the SERS signal from 
the 4-MBA SAM on the planar substrate.  Without the nanocubes the 4-MBS SAM has no 
detectable Raman signal, but upon addition of gold nanocubes the bands associated with the ring 
breathing modes, the bending of the CH groups on the ring, and the stretching associated with 
the carboxylate groups all begin to appear.  The data in this paper suggest that the intensity of 
these vibrational bands depends on the surface coverage of the nanoparticles, but not their 
aggregation state per se.  
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Chapter 4 
 
Using Gold Nanorods to Probe Cell-Induced Collagen Deformation  
 
4.1 Introduction 
 It is well known that a cell responds to changes in its mechanical environment and that 
this response is critical to cell/tissue function.1-8 There have been many studies in this area in 
which physical cues, transmitted through a collagenous network, are used to trigger mechanical 
and biochemical responses by different types of cells.1-8  The mechanism by which cells convert 
a mechanical stimulus into mechanical and biochemical responses is called 
mechanotransduction.  Most studies to this point have focused on either the bulk mechanical 
response of tissue or the response of isolated cells that have had a mechanical load applied.1-9  
However, to understand the complex mechanisms associated with mechanotransduction there 
needs to be an in vitro model to characterize the local mechanical environment on the scale of 
microns.10   
 In the past several years there has been an increase in research in the field of 
nanotechnology due to the unusual physicochemical and optoelectronic properties of 
nanomaterials.  For metals like gold, silver, and copper, decreasing the size of a material below 
the electron mean free path leads to an intense absorption (commonly referred to as a plasmon) 
in the visible—near-infrared region of the electromagnetic spectrum.11  The ability to tune the 
properties of metallic nanomaterials by simply manipulating their size and shape makes them 
                                                
  * This chapter has been adapted from work published in Nano Letters.  Stone, J. W.; Sisco, P. N.; Goldsmith, E. C.; Baxter, S. C.; Murphy, C. J. 
Nano Lett. 2007, 7, 116-119. (Reproduced by permission of The American Chemical Society and co-authors) 
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ideal for use in Biomedical applications.11  The position and number of these Plasmon bands can 
also be tailored by controlling nanoparticle size, shape, aggregation state, and surface 
chemistry.12-15 
 This chapter details experiments in which gold nanoparticles are used to track real time 
cell-induced deformations in a collagen matrix.  This work is done in continuation of our 
previous work in which we show that the scattering of gold nanorods can be used to track strain 
fields as a result of local deformation in streched polyvinyl alcohol and poly(dimethylsiloxane) 
thin films.16  The work presented in this chapter was preformed by embedding gold nanorods in  
thin cell populated collagen films.  The cells used in these experiments are neonatal cardiac 
fibroblasts, which due to the traction forces caused during their manipulation of the extra cellular 
matrix (ECM) create local deformations in the collagen network that we can monitor using 
digital image analysis.  The non-bleaching pattern created by dispersing the gold nanorods on the 
surface of the thin film shifts and deforms as the cells remodel their enviroment.  The 
deformation of this light pattern can be used to track the manipulation of the ECM by the 
fibroblasts, and to calculate local material deformations and the resultant strain fields.  
Fluorescence imaging is also preformed on the samples to identify cell locations, movement and 
morphology.  The fluorescent images also show what is happening at the cellular level in order 
to create the strain fields obtained by digital image analysis. 
 
4.2 Experimental Section 
4.2.1 Materials: :  Chloroauric acid (HAuCl4.3H2O), sodium borohydride (NaBH4), and ascorbic 
acid were obtained from Aldrich and used as received. Ultrapure Hexadecyltrimethylammonium 
bromide (CTAB), HEPES buffer, and 10X minimal essential medium (MEM) were all obtained 
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from Sigma. All nanorod growth reactions were done using 18 MΩ deionized water.  All of the 
glassware used in nanorod growth reactions was cleaned by aqua regia and rinsed with deionized 
water prior to use.  Collagen type I and cardiac fibroblasts (passage numbers between 0 and 4) 
were provided by the University of South Carolina School of Medicine core cell culture facility. 
 
4.2.2 Preparation of Gold Nanorods: Gold nanorods were synthesized by a seed-mediated 
surfactant-directed approach.17-19  The seed was synthesized by the reduction of an aqueous 
solution containing 2.5 x 10-4 M HAuCl4 and 0.1 M CTAB by 0.01 M ice-cold NaBH4.  After 15 
minutes, this seed was used in a three step seeding procedure to prepare gold nanorods.  Two test 
tubes each containing 9 mL of growth solution consisting of 0.1 M CTAB and 2.5 x 10-4 M 
HAuCl4 were prepared and labeled as test tube A and B.  A third 90 mL growth solution was also 
prepared in a 125 mL Erlenmeyer flask.  50 uL of a 0.1 M ascorbic acid solution was added to 
each of the test tubes, and 500 uL was added to the flask.  Next 1.0 mL of the 3.5 – 4 nm seed 
solution was added and mixed with test tube A.  After 15 seconds 1.0 mL of the solution in test 
tube A was added to B and mixed thoroughly.  30 seconds after the addition to test tube B the 
entire nanoparticle solution from B was poured into the growth solution in the flask and mixed.  
The solution was allowed to sit overnight (12-14 hours).  The next day purple supernatant was 
poured off leaving the rods at the bottom of the flask.  The rods were then resuspended in 20 mL 
18 MΩ deionized water and purified by centrifugation (2 x 4000 RCF for 5 minutes).  The long 
rods are coated with a bilayer of CTAB, a cationic surfactant, which renders the nanorods highly 
positively charged and water soluble.20,21  It has been previously determined that these CTAB 
coated rods are not toxic to human cells.22 These long rods were characterized by transmission 
electron microscopy (TEM) on the Hitachi H-8000 electron microscope.  TEM grids were 
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prepared by placing 8 uL of the purified particle solution on a carbon-coated copper grid and 
evaporating the solution at room temperature.  Statistical analysis was performed on a sample of 
100 particles. 
 
4.2.3 Preparation of Collagen Thin Films: Collagen thin films were prepared by adding 250 
uL of a neutralized collagen solution to a square chamber slide. The neutralized collagen was 
prepared by combining 100 uL of 0.2 N HEPES buffer (pH 9.0), 100 uL of 10X MEM, and 800 
uL of type I collagen.  The film was allowed to cure at 40 oC for >2 hours.  After curing a second 
250 uL layer of collagen was added to the slide.  To this second layer 25 uL of a purified long 
gold nanorod solution (aspect ratio 14) was added dropwise, being sure to cover the entire area.  
The resulting film was cured overnight at 40 oC. The following day the film was washed with 
water to remove any salt buildup on the surface, as well as, to hydrate the collagen thin film.  
Once hydrated the films were plated with 100,000 neonatal rat cardiac fibroblasts.  Once the thin 
films were plated with cells they were incubated at 37 oC for five hours in a 5 % CO2 
environment prior to imaging.  45 minutes before imaging the cells were stained with a 
fluorescent dye, 5-chloromethyl-fluoresceindiacetate (CMFDA, excitation wavelength range = 
450-490 nm).  The films were imaged using a Nikon Eclipse model ME600L microscope 
equipped with bright field, dark field, and fluorescent imaging capabilities.  The excitation 
wavelength range for the fluorescence imaging was 450-490 nm. 
  
4.3 Results and Discussion 
 100,000 neonatal rat cardiac fibroblasts isolated from four-day-old neonates were plated 
on gold nanorod doped collagen thin films.  Darkfield and fluorescent images of the nanorod/cell 
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containing collagen thin films were collected over a 2 hour period experimentally determined to 
yield the most movement between 5-7 hours after plating.  The cells were plated on the 
polymerized collagen/nanorod films and incubated at 37 oC and 5% CO2 for one hour to allow 
for the cells to adhere to the collagen matrix before the initial time point.  After the cells had 
adhered to the matrix the cells were given 5 hours to mature on the collagen matrix.  At the 5 
hour mark the films were monitored using darkfield and fluorescent microscopy.  Images were 
collected from multiple cell domains every 20 min for the entire 2 hour interval.  The images 
collected over the two hour period allowed for the measurement of cell-induced collagen 
deformations around individual cells as well as between cells.  Figure 4.1 shows the imaging 
modes used from right to left: the cell field, an overlay of the darkfield scattering of our gold 
nanorods and the cell field, and the darkfield scattering of the gold nanorods.  The amount of cell 
movement can be seen in the fluorescence images seen in figure 2.2.  These images were taken at 
the beginning (left) and end (right) of the two hour imaging session.  There is a both a clear 
change in cell morphology as well as a retraction of the cell extension.  For a more clear and 
compelling visualization of this cell movement there is a movie of the cell movement that 
accompanies the publications at: 
http://pubs3.acs.org/acs/journals/supporting_information.page?in_manuscript=nl062248d 
   
 
 
 
 
 
75 
 
 
Figure 4.1: (Left) dark field image of light scattered by gold nanorods in collagen, (Right) 
fluorescent image of the cells in collagen stained with CMFDA, (middle) overlay of the dark 
field and fluorescence showing where the cells are in regards to the rods. (Inset) TEM image of 
the gold nanorods used in the experiments. (scale bar for the inset is 100 nm)    
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Figure 4.2: Fluorescent images of cells at time points 5 hr. (left) and 7 hr. (right) showing 
changes in cell shape as the cells alter their environment. 
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 It has been well documented that a collagen construct does not act as a homogenous 
material.24  The collagen microstructure can vary in density and mechanical properties 
throughout the material; thereby, resulting in nonuniform responses to the same load.24  Most cell 
motion seen in the fluorescent images over the two hour imaging session will result in 
corresponding deformations of the surrounding collagen, but since the cells are attached to a 
nonuniform substrate the deformations may not be along the outline or the cell some may be seen 
away from the cell. 
 These displacement fields were tracked using an image correlation software developed at 
the University of South Carolina called VIC-2D©.25  VIC-2D© converts the images into grey 
scale and uses gray scale pixel intensities to correlate spatial locations in an undeformed 
reference state to locations in the images taken at different stages of deformation.  The operator 
has to define a matrix size, where the matrix is a set of gray scale pixel intensities in one small 
area of the image being analyzed, and the program will compare the undeformed and deformed 
images by using an optimization algorithm to compare each small area of the image.  Once the 
algorithm is satisfied the software pattern matches the areas and calculates the deformation.  For 
our images the spatial locations corresponds to the non-bleaching pattern in the collagen created 
by the scattering of light by our gold nanorods.  When the software converts our images into grey 
scale pixel intensities it converts the image into a set of pixels that are either gray if there are no 
nanoparticles or white in the pixels that contain nanoparticles.  As the cells move the collagen 
the nanoparticles that are embedded in the collagen film are displaced, causing the pixels in the 
grey scale image to be displaced.  This allows us to measure displacement values directly from 
the initial maping of the darkfield images.  The software then approximates strains from the 
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displacement maps using finite strain theory.  The strains calculated are langrangian strains since 
we measure larger non linear strains. 
 Figure 4.3 shows the contour maps of the strain along the x-axis at time points 320, 400, 
and 420 min.  It also shows both the position of the cells in the fluorescent image as well as an 
overlay of the contour map over the cells to show where the strain fields are in regard to the cells 
causing the displacements.  Compressive strains are labeled negative and are denoted by a violet 
color.  Tensile strains are labeled positive and are denoted by a red color.  It can be seen in 
Figure 4.3 that the strain runs from a maximum compressive strain of -0.0015 to a maximum 
tensile strain of 0.0038.  Small changes in focusing could cause false strain results; therefore, 
control experiments were performed in which we focused and defocused the microscope taking 
images at all stages of focus.  The images were then analyzed using VIC-2D© and strain fields 
were calculated.  It was found that the strains that resulted from the refocusing of a single image 
were 0.00002, far smaller than any strains measured from the cell displacements.    
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Figure 4.3: Images of the cells and their corresponding strain fields.  (Left row)  Images of the 
cells at time points 320, 400, and 420 minutes from top to bottom.  ( Middle row) overlay of the 
strain fields on the same cell images showing which cells are producing the most strain.  (Right 
row) image of just the strain fields.  (general information) The color scale at the bottom runs 
from maximum compressive strain at -0.0015 (violet) to maximum tensile strain at 0.0038 (red) 
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 Figure 4.4 shows a quantitative examination of the strain plots by analyzing axial strain 
as a function of position.  The inset in Figure 4.4 shows the horizontal line denoting the set of 
strain values on the plot.  It can be clearly seen that regions of the collagen/nanorod/cell 
composite material could experience a 6-fold increase in strain (pixel 72) or a 3-fold decrease in 
strain (pixel 55).  It can also be seen from the plot of tensile strain around pixel 72 that the cell is 
pulling the collagen towards itself from 320 min to 400 min; however, at 420 min the tensile 
strain goes down slightly meaning the cell has started to relax.  The strain fields we see in our 
system are around 0.3 % tensile strain and 0.15 % compressive strain.  Work from Vanni et al, 
who use the collagen microstructure itself as a in situ strain gauge, shows strains around 20-
36%.26  However they were using a period of 60 hours and sparsely populated collagen gels 
instead of thin films.  Wang et al have measured displacements of around 3 microns by tracking 
cells in a polyacrylamide gel embedded with fluorescent beads.  The maximum displacement in 
our system is on the order of 18 microns, but our system is done in a much more compliant 
medium.  By using the scattering of metallic nanoparticles our system also does not suffer from 
photobleaching effects that most fluorescent methods do.   
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Figure 4.4: Plot of axial strain as a function of pixel position across the image over different 
time intervals.  The area extracted can be seen as the black line in the inset of the strain field. The 
lines all represent different time points: Light dashed line, 320 minute; thick solid line, 360 
minute; thin solid line, 400 minute; dark dashed line, 420 minute. 
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4.4 Conclusion 
 Developing a method to quantify local mechanical effects in tissue at relevant length 
scales will help in the understanding of the mechanism of mechanotransduction.  The resulting 
correlations will give a more accurate model of how heart tissue responds to changes in its 
environment.  This provides the groundwork for developing cardiac therapeutics. It has been 
shown that cellular response is different in a more tissue like 3-D environment, as compared to 
flat planar substrates; therefore, it is critical that measurements can be made in a tissue like 
environment.  Our system is still by nature a 2-D system in that it is a film attached to a 
microscope slide, however we demonstrate the ability to track local deformations in real time 
with a thick collagen film.   Our method also allows for the analysis of strain fields not only 
under one cell but between multiple cells.  The use of metallic nanoparticles for biological 
applications is not a new concept there have been multiple other investigators that have used the 
optical properties of metallic nanoparticles to detect biological molecules and image the transport 
process into a cell.28-34  The data presented here shows the potential to use metallic nanoparticles 
for chemical studies in conjunction with mechanical studies, which will provide much more 
information about the environments around living cells.   
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Chapter 5 
 
The Effect of Gold Nanorods on Cell-Mediated Collagen Remodeling  
 
5.1 Introduction 
Gold nanomaterials have received considerable attention due to unique optical 
properties1-3 which make them ideal platforms for biomedical research in biosensing1, cell 
tracking4, imaging5,6, drug delivery7, and therapeutics.8  For biomedical applications, a 
fundamental understanding of how cells interact with and respond to an environment containing 
gold nanomaterials is crucial.  There have been multiple studies documenting the cellular uptake 
and cytotoxicity of gold nanoparticles in different cell types;9-11 but very little is known about 
how nanoparticles affect cellular functions or interactions between the cells and their 
extracellular matrix (ECM).  Gold nanorods have been used as pattern markers to measure 
neonatal cardiac fibroblast-induced strain fields in a two-dimensional collagen matrix.5   
However, cells on a two-dimensional substrate behave differently than in a three-dimensional, 
tissue-like environment.12,13 
To determine if gold nanorods alter the behavior of cardiac fibroblasts in a more in vivo 
like environment, the ability of neonatal rat cardiac fibroblasts to remodel three-dimensional type 
I collagen gels was examined.  Fibroblasts account for ~30% of the cells in the neonatal rat 
heart,14 and their primary function is to regulate the abundance and organization of extracellular 
matrix proteins, including type I collagen. Collagen production increases dramatically in the 
                                                
  * This chapter has been published in Nano Letters.  Sisco, P. N.; Wilson, C. G.; Mironova, E.; Baxter, S. C.; Murphy, C. J.; Goldsmith, E. C. 
Nano Lett. 2008, 8, 3409-3412. (Reproduced by permission of The American Chemical Society and co-authors) 
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neonatal heart,15 an adaptation to increased mechanical load, and is organized into a network 
similar to that observed in the adult heart.16  Three-dimensional collagen gels are good in vitro 
models of tissue remodeling,12 and have been used extensively to examine factors influencing 
cardiac fibroblast matrix remodeling.17,18  During the process of tissue remodeling, a fibroblast 
undergoes a phenotypic switch to a myofibroblast, characterized by up-regulation of α-smooth 
muscle actin and increased production of ECM proteins.19  Myofibroblasts reorganize the ECM 
by attaching and pulling on the collagen-rich matrix and undergo apoptosis when the remodeling 
process is complete.20   
 
5.2 Experimental Section 
5.2.1  Materials:  Chloroauric acid (HAuCl4.3H2O), sodium borohydride (NaBH4), and ascorbic 
acid were obtained from Aldrich and used as received.  The polyelectrolytes, poly(sodium-4-
strenesulfonate) (PSS), Mw ~ 70,000 g/mol and poly(diallyldimethylammonium chloride) 
(PDADMAC), Mw ~ 15,000 g/mol, were obtained from Aldrich and used as received.  Ultrapure 
Hexadecyltrimethylammonium bromide (CTAB), HEPES buffer, 10X minimal essential medium 
(MEM), and triton X-100 were all obtained from Sigma.  Sodium chloride (NaCl) was purchased 
from Fisher chemicals. Gelatin, Coomassie blue, and molecular weight markers were purchased 
from BioRad.  All nanorod growth reactions were done using 18 MΩ deionized water.  All of the 
glassware used in nanorod growth reactions was cleaned by aqua regia and rinsed with deionized 
water prior to use.  
  
5.2.2  Synthesis of Gold Nanorods:  Gold nanorods were synthesized by a seed-mediated 
surfactant-directed approach.  The seed was synthesized by the reduction of an aqueous solution 
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containing 2.5 x 10-4 M HAuCl4 and 0.1 M CTAB by 0.01 M ice-cold NaBH4.  After 15 minutes, 
this seed was used in a three step seeding procedure to prepare gold nanorods.  Two test tubes 
each containing 9 mL of growth solution consisting of 0.1 M CTAB and 2.5 x 10-4 M HAuCl4 
were prepared and labeled as test tube A and B.  A third 90 mL growth solution was also 
prepared in a 125 mL Erlenmeyer flask.  50 µL of a 0.1 M ascorbic acid solution was added to 
each of the test tubes, and 500 µL was added to the flask.  Next 1.0 mL of the 3.5 – 4 nm seed 
solution was added and mixed with test tube A.  After 15 seconds 1.0 mL of the solution in test 
tube A was added to B and mixed thoroughly.  30 seconds after the addition to test tube B the 
entire nanoparticle solution from B was poured into the growth solution in the flask and mixed.  
The solution was allowed to sit overnight (12-14 hours).  The next day purple supernatant was 
poured off leaving the rods at the bottom of the flask.  The rods were then resuspended in 20 mL 
18 MΩ deionized water and purified by centrifugation (2 x 4000 RCF for 5 minutes).  These 
long rods were characterized by transmission electron microscopy (TEM) on the Hitachi H-8000 
electron microscope.  TEM grids were prepared by placing 8 uL of the purified particle solution 
on a carbon-coated copper grid and evaporating the solution at room temperature.  Statistical 
analysis was performed on a sample of 100 particles. 
 
5.2.3  Polyelectrolyte Coating of Gold Nanorods (LbL Deposition):  Aliquots (1.5 mL) of as-
prepared gold nanorods were added to microcentrifuge tubes and centrifuged once at 4000 RCF 
for 5 min.  A pellet of gold nanorods was formed at the bottom of the microcentrifuge tubes.  
The supernatant was slowly removed without disturbing the pellet.  For polyelectrolyte coating 
two pellets were combined into 1 mL 18 MΩ deionized water. 
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Ten mg/mL stock solutions of PSS and PDADMAC were prepared in 1 mM aqueous 
NaCl solution.  To the microcentrifuge tubes containing 1 mL concentrated gold nanorods 100 
uL 10 mM NaCl and 200 µL of PSS stock solution were added simultaneously.  After 30-min. 
adsorption time, the excess polymer in the supernatant fraction was removed by centrifugation at 
4000 RCF for 5 min.  The resulting pellet was redispersed in 1 mL 18 MΩ deionized water and 
the process was repeated two more times with PDADMAC first then again with PSS.  The 
charge on the nanorods was measured using a ZetaPALS zeta potential analyzer from 
Brookhaven Instruments Corporation. 
 
5.2.4  Preparation of Three-dimensional Collagen Gels Containing Nanorods and Cardiac 
Fibroblasts:  One mL of a polymer-coated long nanorod solution was centrifuged at 4000 RCF 
and resuspended in 1 mL of type I collagen (Inamed) buffered with HEPES and supplemented 
with 10X MEM at a 8:1:1 (v/v/v) ratio.  Neonatal cardiac fibroblasts were isolated by enzymatic 
digestion and selective attachment from neonatal day 3 rat hearts as previously described21 and 
used prior to passage three. Neonatal rat cardiac fibroblasts were added to the neutral collagen 
solution at a final concentration of 200,000 cells/mL.  In a 96 well plate, 100 µL gels were cast 
and maintained in a humidified 37 oC incubator in 5% CO2 for one hour.  After one hour the gels 
were detached from the sides of the wells, cell growth media [DMEM supplemented with 10% 
newborn bovine serum, 5% fetal bovine serum (Atlanta Biological; Atlanta, GA), 100 U/ml 
penicillin G, 100 µg/ml streptomycin, 1 µg/ml amphotericin B] was added and gels were 
incubated as described above for 24 hours.  Contraction was determined from image analysis of 
digital photographs taken at 4, 8, 12, and 24 hours after polymerization.   
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5.2.5  Cell Viability Assays:  Analysis of cell viability was carried out using a live: dead assay 
kit (MarkerGene) as per manufacturer’s recommendations.  Gels were washed several times in 
Moscona’s saline (136.8 mM NaCl, 28.6 mM KCl, 11.9 mM NaHC03, 9.4 mM glucose, 0.08 
mM NaH2P04, pH 7.4) to remove any excess media in the gels before being stained.  The 
staining solution was prepared by diluting fluorescent reagents A (carboxyfluorescien diacetate) 
and B (propidium iodide) in Moscona’s buffer.  The gels were incubated in the staining solution 
for one hour at 37oC at 5% CO2.  After staining, the gels were washed several times with PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4; pH 7.4) and imaged using 
a Ziess LSM 510 META confocal imaging system. 
 
5.2.6  Gelatin Zymography:  To examine the activation of MMP2, conditioned media was 
removed from fibroblasts cultured in collagen gels containing differing amounts of gold 
nanorods.  Twenty uL of media was mixed with an equal volume of 2x SDS-PAGE loading 
buffer and loaded onto a 10% polyacrylamide gel containing gelatin at a final concentration of 1 
mg/mL.  Following electrophoresis, gels were rinsed twice in 2.5% Triton X-100 followed by an 
overnight incubation at 37oC in Tris (pH 8.0) containing 5 mM calcium chloride.  Gels were 
stained with Coomassie Blue, destained in distilled water and resulting MMP2 bands 
(determined using molecular weight markers) were imaged on a Bio-Rad Gel Doc system and 
quantified with ImageJ. 
 
5.2.7  Real Time-Polymerase Chain Reaction (RT-PCR):  Total mRNA was isolated using 
TRIzol reagent (Invitrogen) as indicated in manufacturer instructions. Complementary DNA was 
prepared on 100 ng of total mRNA using iScript™ cDNA Synthesis kit (BioRad) according to the 
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manufacturer’s instruction. Real time PCR was performed using iQ™ SYBR® Green Supermix 
(BioRad) in a MyiQ™ Single Color Real-Time PCR Detection System (BioRad) under the 
following conditions: 95oC for 2.5 min followed by 40 cycles of 95oC for 10 sec and 55oC for 45 
sec followed by the melting curve protocol. Melting curve analysis determined the specificity of 
the amplified products and the absence of primer-dimer formation. All values were normalized 
using the housekeeping gene acidic ribosomal phosphoprotein P0 (ARBP) as an internal control. 
The following primers were purchased from Integrated DNA Technologies: β-actin sense, 5’-
CGT GCG TGA CAT TAA AGA G-3’; antisense, 5’-GCC ACA GGA TTC CAT ACC-3’; α-
smooth muscle actin sense, 5’-GGA GTG ATG GTT GGA ATG G-3’; antisense 5’-ATG ATG 
CCG TGT TCT ATC G-3’; Collagen I sense, 5’-GCG AAG GCA ACA GTC GAT TC-3’; 
antisense, 5’-CCC AAG TTC CGG TGT GAC TC-3’; ARBP sense, 5’-TAG AGG GTG TCC 
GCA ATG-3’; antisense 5’-GAA GGT GTA GTC AGT CTC C-3’. The PCR data were analyzed 
by Relative Expression Software Tool (REST-XL, http://www.wzw.tum.de/gene-
quantification/). 
 
5.3 Results and Discussion 
To examine the effects of gold nanorods on cell-mediated matrix remodeling, varying 
amounts of polymer-coated gold nanorods were added to a solution of neutralized collagen, 
which was then seeded with 200,000 neonatal rat cardiac fibroblasts.  Gold nanorods (392 ± 93 
nm long, 22 ± 3 nm wide) were prepared in aqueous solution using a seed-mediated surfactant-
directed approach previously described and purified by centrifugation and washing.22-24  Using 
layer-by-layer (LbL) assembly25, three layers of oppositely charged polyelectrolytes 
[poly(diallyldimethylammonium chloride), PDADMAC; poly(styrene sulfonate), PSS] were 
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deposited on the surface of the nanorods terminating in PSS.  The polymer coating was used to 
render the nanorods anionic in aqueous solution, to mask the surfactant bilayer, and reduce 
potential toxicity.  Nanorod-collagen-fibroblasts composite gels were prepared by adding 100 µL 
of a solution containing 100 µL 0.2N HEPES buffer (pH 9.0), 100 µL 10X MEM, 800 µL type I 
collagen, 200,000 neonatal rat cardiac fibroblasts, and varying concentrations of gold nanorods 
(maximum concentration ~ 20 pM) to a 96 well cell culture plate.  The nanorod-collagen-
fibroblasts composite gels were allowed to polymerize for 1 h at 5 % CO2 and 37 ºC, detached 
from the surface of the culture plate, and the contraction of these gels monitored over a 24 hour 
time period.  The addition of polymer-coated nanorods to cardiac fibroblast seeded collagen gels 
resulted in a significant (p<0.05) dose-dependent inhibition of fibroblast-mediated contraction 
(Figure 5.1).  The highest concentration of nanorods (5.6 x 109 nanorods/gel) inhibited gel 
contraction by approximately 10% compared to control gels without nanorods. In addition to 
impaired contraction, a qualitative difference in the stiffness of collagen gels prepared with 
nanorods was observed.  Control gels lacking nanorods appeared more rigid and better able to 
hold their shape; in contrast, collagen-nanorod composite gels were more fluid.  Transmission 
electron microscopy showed that within the collagen gels, the nanorods were predominantly 
associated with the collagen (Figure 5.2) and in only a few instances were nanorods detected 
inside the fibroblasts.  Turbidity experiments revealed that polymer-coated nanorods reduced the 
lag time of collagen fibrillogenesis but did not alter the equilibrium of polymerization (data not 
shown).  Confocal reflectance microscopy (Figure 5.3) showed qualitatively similar collagen 
distribution within the gels, suggesting the nanorods do not substantially alter collagen 
organization. 
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Figure 5.1: Gold nanorods inhibit fibroblast-mediated collagen gel contraction. A. Photograph 
of fibroblast-seeded collagen gel without gold nanorods (diameter ~6.5 mm, in a standard 96 
well plate) at time zero.  B. The same gel from A after 24 hr.  C. Photograph of fibroblast-seeded 
collagen gel with gold nanorods (which provide the color) at time zero.  D. The same gel from C 
after 24 hr.  E. Percent change in gel diameter as a function of time. (open square – 2 mg/mL 
Type I Collagen with 0 nanorods/mL, black square – 1.4 x 109 nanorods/gel, open diamond – 2.8 
x 109 nanorods/gel, black diamond – 5.6 x 109 nanorods/gel) 
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Figure 5.2:  A.  Representative TEM micrograph showing the nanorods are predominantly 
associated with the collagen. (Scale bar 100 nm)  B.  TEM micrograph showing that some of the 
gold nanorods were detected inside fibroblasts (dark spots indicated by arrow). (Scale bar 500 
nm)   
 
 
 
 
 
 
 
 
A B 
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Figure 5.3: Confocal reflectance images of the collagen microstructure in control (A) and 
nanorod-containing (B) constructs. Images were collected at identical magnifications. Scale bar 
= 25 µm. 
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The reduced gel contraction observed in the presence of gold nanorods was not due to 
cell death or a decrease in cellular ability to degrade the ECM, as measured by a number of 
assays.  A fluorescence cell viability assay showed no difference in fibroblast survival (~86% 
viability) between control and nanorod-treated gels (Figure 5.4).  In addition, lactate 
dehydrogenase release assays indicated that there was no difference in cell necrosis between gels 
with and without nanorods (Figure 5.5).  Taken together, these results suggest that the observed 
decrease in gel contraction was not due to nanorod cytotoxicity.  Gelatin zymography was used 
to examine the level of matrix metalloproteinase activity in conditioned media from contracted 
collagen gels.  Previous work has shown that during gel contraction, cardiac fibroblasts produce 
matrix metalloproteinase 2 (MMP2) and that this enzyme is crucial for the contraction and 
remodeling process.26  No significant differences in MMP2 activity were detected between 
control and nanorod-containing constructs (Figure 5.6), suggesting that the fibroblasts’ ability to 
degrade the ECM was not significantly affected by the presence of the nanorods. 
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Figure 5.4: (Top). Representative confocal images of cardiac fibroblasts in collagen gels with no 
rods (left) or 5.6 x 109 nanorods/gel (right).  Red staining denotes dead cells and green staining 
denotes living cells.  Scale bar = 100 µm.  (Bottom) Histogram showing results of analysis of 
confocal images (n = 800 cells for each treatment).  Student’s T test was used to determine 
significance.   
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Figure 5.5:  Gold nanorods do not induce cell necrosis. Culturing fibroblasts in the presence of 
gold nanorods did not stimulate cell necrosis as evident in this LDH study.  (Light grey diamond 
– 1.4 x 109 nanorods/gel, dark grey diamond – 2.8 x 109 nanorods/gel, black diamond – 5.6 x 109 
nanorods/gel) 
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Figure 5.6:  Gold nanorods to not modulate MMP2 Activity. Graphical illustration of the 
quantification of MMP-2 levels from fibroblasts cultured in collagen gels with varying amounts 
of gold nanorods present. (Black – 5.6 x 109 rods/gel, Grey – 2.8 x 109 rods/gel, Dark Grey – 1.4 
x 109 rods/gel, and Light Grey – 0 rods/gel.)  There is no significant difference in MMP-2 
expression between the gels as determined by a Student’s T-test.  Zymography experiments were 
repeated in triplicate.   
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The transition of fibroblasts to a myofibroblast phenotype is a critical event in the 
remodeling process.19  A hallmark of this transition is an increase in the expression of α-smooth 
muscle actin (α-sma) and an increased contractility.19  Quantitative real-time PCR was carried 
out on RNA isolated from collagen gels after 24 hours to determine if there was a change in the 
fibroblast phenotype.  In addition to measuring the expression of α-smooth muscle actin, the 
changes in expression of type I collagen and β-actin mRNAs were also measured.  Collagen 
expression is expected to increase during remodeling, and previous work has shown that β-actin 
is increased in non-contractile regions of cells.27  A dramatic difference in the expression of these 
genes was detected in cardiac fibroblasts cultured in collagen gels with and without gold 
nanorods (Figure 5.7).  Collagen-nanorod constructs exhibited a significant 447 percent increase 
in β-actin gene expression compared to control gels (p<0.001; Figure 5.7).  The levels of mRNA 
coding for both α-smooth muscle actin and type I collagen were significantly (p<0.001) down-
regulated in the presence of gold nanorods, by 93 and 69 percent respectively, indicating that 
there was less α-smooth muscle actin and collagen I expression in gels containing gold nanorods 
as compared to control gels (Figure 5.7).  Based on this evidence, polymer coated nanorods 
induced changes in gene expression in cardiac fibroblasts within collagen gels and interfered 
with the transition of the fibroblasts to a more contractile myofibroblast phenotype. 
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Figure 5.7: Real time PCR analysis of cardiac fibroblast gene expression. In the presence of 
polymer-coated gold nanorods, expression of β-actin was 2.2 ± 0.3 fold higher than controls 
while expression of α-smooth muscle actin and type I collagen were 3.9 ± 1.3 and 1.7 ± 0.1 fold 
lower, respectively, compared to gels without nanorods. All differences were statistically 
significant (p<0.001 using a pair wise fixed reallocation randomization). 
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With the growth of the nanotechnology field, there is increasing interest in characterizing 
and understanding the effects that nanoparticles have on biological systems with the goal of 
ultimately using these particles for biomedical imaging, diagnostics and therapeutic approaches.  
Previous studies have shown that nontoxic gold nanoparticles can be made and used for 
biomedical applications.28  Nanoparticles have been used for imaging cell-induced changes in the 
local mechanical environment4 and for identification of tumor cells.29 By exploiting the 
photothermal properties of nanomaterials, these particles have been used to selectively target and 
destroy tumor cells.8 At the cellular level, a size-dependent response has been reported for 
treatment of cancer cells with functionalized nanoparticles, resulting in changes in both protein 
levels and cell apoptosis.11,30,31  What is unclear is how the responses measured to date will 
translate into cell behavior on a three-dimensional, tissue scale. 
 
5.4 Conclusion  
The results of this study offer insight into the cellular response of cardiac fibroblasts to 
gold nanorods on a tissue-like scale.  Related work with lung fibroblasts has shown that ultrafine 
carbon black particles (~ 14 nm in diameter), but not fine particles (~ 260 nm in diameter), also 
reduced cell-mediated 3D collagen gel contraction.32 This effect was attributed, in part, to 
adsorption and sequestration of factors known to regulate matrix remodeling, including 
transforming growth factor β (TGF-β) and fibronectin.32 It has also been shown that 
carboxylated single-walled carbon nanotubes delay, but do not inhibit, collagen gel compaction 
by aortic smooth muscle cells with minimal cytotoxicity and little effect on cell morphology, but 
the mechanism remains unclear.33 In our studies, polyelectrolyte-coated gold nanorods, in the 
size range of the fine carbon black particles, substantially altered the matrix-remodeling behavior 
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of cardiac fibroblasts by interfering with the transition of these cells into myofibroblasts, highly 
contractile cells which produce collagen and other extracellular matrix proteins as part of a 
normal wound healing response.  Due to differences in cell type and nanomaterial preparations, it 
is difficult to compare our results with previous reports. Taken together, however, these studies 
reveal several nanomaterial-induced effects that likely depend on particle size, morphology, and 
surface chemistry and require further investigation.   
 Although initially beneficial, continued myofibroblast activity can result in excessive 
collagen deposition (fibrosis) contributing to progressive organ dysfunction.  Myofibroblasts are 
not found within normal myocardium, but arise in response to pathological stimuli and play a 
pivotal role in the fibrotic response associated with decreased cardiac function observed in 
hypertrophic and dilated cardiomyopathies.34  Currently, few therapeutic approaches exist which 
specifically target the synthetic activity and transition of fibroblasts into myofibroblasts.  The 
ability to modulate gene expression and fibroblast phenotype suggests that nanoparticles could 
serve as novel therapeutic agents in regulation of cardiac fibrosis and wound healing.  
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Chapter 6 
 
Adsorption of Cellular Proteins to Polyelectrolyte-Functionalized Gold Nanorods: A 
Mechanism for Nanorod Control of Cell Phenotype 
 
6.1 Introduction 
Gold nanomaterials have received considerable attention for use in biomedical 
applications due to their unique optoelectronic properties1-3 which make then ideal for research in 
cellular tracking4, imaging5,6, biochemical sensing1, drug delivery7, and therapeutics8.  In order to 
study biomedical applications of gold nanorods, a fundamental understanding of how cells 
interact with and respond to an environment containing nanorods is crucial.  There have been 
multiple studies documenting the cellular uptake and cytotoxicity of gold nanoparticles in 
different cell types9-11.  There have also been several studies describing the relationship between 
the surface chemistry of nanoparticles and serum protein adsorption12-14; however, little is known 
about how protein adsorption to nanoparticles can affect cellular functions or interactions 
between the cells and their extracellular matrix (ECM).  For many in vitro and in vivo 
applications, the local environment around the nanoparticles will be rich in soluble proteins 
(present in serum and interstitial fluid), insoluble ECM proteins such as collagen, and cell 
surface proteins.   
Recently, we reported that gold nanorods coated with polyelectrolyte multi-layers 
terminated with poly(styrene sulfonate) (PSS) substantially altered the matrix-remodeling 
behavior of rat cardiac fibroblasts in type I collagen gels15.  We observed that cardiac fibroblasts 
suspended in 3-dimensional collagen hydrogels doped with PSS-coated gold nanorods had lower 
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expression of mRNAs encoding α-smooth muscle actin and collagen type I than controls, 
indicating that biocompatible nanorods have the capacity to alter the phenotype of the cells in 
vitro15.  This unexpected result could be highly detrimental to biomedical applications of these 
materials; yet, if properly understood, may also provide a new way to intervene with cell fate in a 
beneficial way.  In addition to the effects nanorods have on cells themselves, nanorods alter the 
physical properties of the matrix that surrounds the cells.  We have quantitatively examined the 
effects of polyelectrolyte-coated nanorods on the polymerization and mechanical properties of 
type I collagen gels, frequently used as a model for tissue16.  Our results showed that anionic 
nanorods altered the mechanical properties, network morphology, and polymerization kinetics of 
type I collagen, while cationic nanorods had only small effects on the same properties16. 
Collectively, these results led us to hypothesize that gold nanorods functionalized with positively 
or negatively charged polymers bind proteins capable of mediating these effects on cells and the 
ECM. It is known that in serum, nanoparticles establish a dynamic protein “corona” composed of 
both tightly bound and loosely bound protein fractions12,13.  The surface chemistry of the 
particles is thought to play a significant role in controlling the nanoparticle-protein interactions 
by virtue of electrostatic interactions between charged nanoparticles and proteins12-14. Here we 
report the identity of numerous proteins that adsorbed to polyelectrolyte-coated gold nanorods 
from cell culture and demonstrate differential binding with positively and negatively charged 
functional groups.  
 
6.2 Experimental Section 
6.2.1 Materials.  Chloroauric acid (HAuCl4.3H2O), sodium borohydride (NaBH4), poly(4-
styrenesulfonic acid- co-maleic acid) sodium salt (PSS-MA; 1:1 4-styrenesulfonic acid: maleic 
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acid mole ratio, MW ∼ 20 000 g/mol), and ascorbic acid were obtained from Aldrich and used as 
received.  The polyelectrolytes, poly(sodium-4-strenesulfonate) (PSS), Mw ~ 70,000 g/mol and 
poly(diallyldimethylammonium chloride) (PDADMAC), Mw ~ 15,000 g/mol, were obtained 
from Aldrich and used as received.  Ultrapure Hexadecyltrimethylammonium bromide (CTAB), 
HEPES buffer, minimal essential medium (MEM), and triton X-100 were all obtained from 
Sigma.  Sodium chloride (NaCl) was purchased from Fisher chemicals. 1-Ethyl-3-[3-
dimethylaminopropyl]carbo- diimide hydrochloride (EDC) was obtained from Pierce Chemicals. 
2-(N- morpholino)ethanesulfonic acid (MES), sodium acetate, calcium acetate, sodium carbonate 
were obtained either from Sigma.  Molecular weight markers and 4-20% gradient SDS-PAGE 
gels were obtained from BioRad.  All rod growth reactions were done using 18 MΩ deionized 
water.  All of the glassware used in rod growth reactions was cleaned by aqua regia and rinsed 
with deionized water prior to use.  Cardiac fibroblasts were enzymatically isolated from neonatal 
(day 3) rat hearts and passaged up to 3 times prior to use. 
 
6.2.2 Synthesis of Gold Nanorods.  Gold nanorods were synthesized using a seed-mediated 
surfactant-directed approach as previously described17-19.  A 3.5-4 nm seeding solution was 
synthesized by the reduction of an aqueous solution containing 2.5 x 10-4 M HAuCl4 and 0.1 M 
CTAB by 0.01 M ice-cold NaBH4.  This seed was allowed to age for 1 h and then used in a three 
step seeding procedure to prepare gold nanorods.  Two test tubes each containing 9 mL of 
growth solution consisting of 0.1 M CTAB and 2.5 x 10-4 M HAuCl4 were prepared and labeled 
as test tube A and B.  A third 90 mL growth solution was also prepared in a 125 mL Erlenmeyer 
flask.  50 µL of a 0.1 M ascorbic acid solution was added to each of the test tubes, and 500 uL 
was added to the flask. Next 1.0 mL of the 3.5 – 4 nm seed solution was added and mixed with 
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test tube A.  After 15 seconds 1.0 mL of the solution in test tube A was added to B and mixed 
thoroughly.  30 seconds after the addition to test tube B the entire nanoparticle solution from B 
was poured into the growth solution in the flask mixed thoroughly and allowed to sit overnight. 
The next day the supernatant was poured off leaving the rods at the bottom of the flask.  The rods 
were then resuspended in 20 mL 18 MΩ deionized water and purified by centrifugation (2 x 
4000 RCF for 5 minutes).  These long rods were characterized by transmission electron 
microscopy (TEM) on a JEOL 2100 Cryo-TEM.  TEM grids were prepared by drop drying 8 µL 
of the purified particle solution on a carbon-coated copper grid at room temperature.  The 
average dimensions of the particles were calculated by measuring no less than 100 particles. 
6.2.3 Polyelectrolyte Coating of gold nanorods (LbL Deposition). 10 mg/mL stock solutions 
of PSS and PDADMAC were prepared in 1 mM aqueous NaCl solution.  To microcentrifuge 
tubes containing 1 mL concentrated gold nanorods 100 uL 1 x 10-2 M NaCl and 200 uL of PSS 
stock solution were added simultaneously.  After 30-min. adsorption time, the excess polymer 
was removed by centrifugation at 4000 RCF for 5 min.  The resulting pellet was redispersed in 1 
mL 18 MΩ deionized water and the process was repeated once more to obtain nanorods 
terminated with  PDADMAC and twice more to obtain rods terminated in PSS or PSS-MA.  The 
charge on the nanorods was measured using a ZetaPALS zeta potential analyzer from 
Brookhaven Instruments Corporation. 
6.2.4 PEG Functionalization of Gold Nanorods. PSS-MA-coated gold nanorods were 
resuspended in 2-(N-morpholino)ethanesulfonic acid (MES) buffer (10 mM, pH 5.5). 50 µL of a 
0.1 M stock solution of methoxyl PEG amine (5k or 350 MW) was added to 1 mL of 
resuspended nanorods.  The reaction was vortexed for 2 min, and then the mixture was allowed 
to sit for 15 min to allow the PEG to interact with the COOH groups of the polymer coated 
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nanorods.  After this, 0.5 mg of EDC powder was added to the solution and vortexed for 2 min.  
The reaction mixture was kept undisturbed overnight.  The solution was purified the following 
day by centrifugation at 4000 RCF for 5 min, and resuspended in water.  The PEG coated 
nanorods were characterized by TEM (JEOL 2100 Cryo-TEM), zeta potential (ZetaPALS), and 
UV-Vis on a Cary 500 from Varian.  TEM grids were prepared by drop drying 8 µL of the 
purified particle solution on a carbon-coated copper grid at room temperature. 
6.2.5 Isolation and Identification of Proteins. The proteins bound to the gold nanorods were 
extracted from the nanoparticles using a 1M NaCl solution.  The particles were then separated 
from the supernatant by centrifugation at 4000 RCF for 5 min.  The resulting supernatant was 
dialyzed (10,000 MW cutoff) against water overnight and run on a 4-20% gradient gel to 
determine purity of the sample and number of proteins.  The supernatant was then sent to 
ProtTech for protein Identification.  At ProtTech the proteins were denatured by adding 8 M 
urea. The Cys residues in the solution sample were reduced by reaction with 20 mM 
dithiothreitol (DTT) and then alkylated by reaction with 20 mM iodoacetamide. After diluting 
the sample to 2 M urea with 100 mM ammonium bicarbonate (pH 8.5), proteins in the solution 
were digested by adding sequencing grade modified trypsin (Promega, Madison, WI). The 
resulted peptides mixture from the digestion was desalted with a PepClean spin column ((Pierce, 
Rockford, IL), and analyzed by a LC-MS/MS system, in which a high pressure liquid 
chromatography (HPLC) with a 75 micrometer inner diameter reverse phase C18 column was 
on-line coupled with an ion trap mass spectrometer (Thermo, Palo Alto, CA). The mass 
spectrometric data acquired from LC-MS/MS analysis were used to search against the recent 
Non-Redundant Protein Database from GenBank (http://www.ncbi.nlm.nih.gov/) with 
ProtTech’s ProtQuest software package.  
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6.3 Results and Discussion 
Gold nanorods (408 ± 97 nm long, 22 ± 3 nm wide) were prepared in aqueous solution 
using a seed-mediated surfactant-directed approach previously described and purified by 
centrifugation and washing17-19.  Using layer-by-layer (LbL) assembly20, layers of oppositely 
charged polyelectrolytes [poly(diallyldimethylammonium chloride), PDADMAC; poly(styrene 
sulfonate), PSS] were deposited on the surface of the nanorods. The polymer coating was used to 
render the nanorods anionic (PSS) or cationic (PDADMAC) in aqueous solution, to mask the 
surfactant bilayer, and reduce potential toxicity15.  
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Figure 6.1: Schematic of protein isolation, purification and identification from both cationic 
(PDADMAC) and anionic (PSS) overcoated gold nanorods. Gold nanorods were prepared as 
described in the text and coated using layer-by-layer assembly yielding nanorods with either a 
positive (PDADMAC) or negative (PSS) surface charge. After incubation with media from 
fibroblast cultures, nanorods were centrifuged and proteins eluted with increasing salt 
concentrations. The resulting fractions were examined by SDS-PAGE and proteins visualized by 
silver staining. 
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Neonatal cardiac fibroblasts were cultured in Dulbeco’s Modified Eagle’s Medium 
containing 10% fetal bovine serum and antibiotics (100 U/ml penicillin G; 100 µg/ml 
streptomycin) for 48 hours. Nanorods were centrifuged to separate them from the media and 
solutions of increasing ionic strength were used to wash the rods (up to 1 M) to remove bound 
protein.  The resulting supernatants containing the extracted proteins were dialyzed (10k MW 
cutoff) against water overnight, then run on a 4-20% gradient SDS-PAGE gel (Figure 6.1) and 
silver stained to examine the number of bands, equating to an approximate number of proteins 
present in the supernatant.  Protein samples were denatured by adding 8 M urea, followed by a 
reduction and alkylation of the Cys residues in solution, followed by tryptic digestion.  The 
digested solutions were then analyzed using a Nanodrop LC-MS/MS system at ProtTech 
(Norristown, PA), and the resulting spectrometric data was identified using the Non-Redundant 
Protein Database from GeneBank with ProtTech’s ProtQuest software package.          
The addition of the polyelectrolyte-coated nanorods to cultured media resulted in 
significant protein uptake as evident by the SDS-PAGE gel in Figure 6.1.  Analysis of silver 
stained SDS-PAGE gels for both the PSS and PDADMAC coated nanorod samples showed the 
presence of at least 5 protein bands ranging from 37 kDa and 250 kDa.  However, Nanodrop 
LC/MS/MS data on the supernatants revealed that the nanorods were adsorbing far more proteins 
than originally expected based on the gel data (Table 6.1). 
 In a combination of two independent analyses, 36 unique proteins were identified which 
bound to the PSS-derivatized nanorods while 33 unique proteins absorbed onto the PDADMAC-
coated nanorods. Of these proteins, 12 associated with the PSS nanorods and 10 with the 
PDADMAC nanorods were identified in both experiments (Table 6.1). 
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Table 6.1: Proteins adsorbed to nanorods identified by mass spec analysis. Proteins are listed in 
alphabetical order. Proteins shown in italics were identified as rat proteins, those in italics and 
bold were from both rat and bovine sources, while all other proteins listed were of bovine origin. 
 
PSS Coated Nanorods PDADMAC Coated Nanorods 
α-1 acid glycoprotein 
α-1 antitrypsin 
α-1-B glycoprotein 
α-2 macroglobulin 
α-2-HS glycoprotein 
albumin 
anti-testosterone 
antibody 
β-2 glycoprotein 
biglycan 
complement C1q 
subunit A 
complement C1q 
subunit B 
complement factor H 
thrombospondin 1 
α-1 acid glycoprotein 
α-2 macroglobulin 
α-2-HS glycoprotein 
albumin 
apolipoprotein A-II 
biglycan 
complement factor B 
Ig Heavy chain 
thrombospondin 1 
transferrin 
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The data in Table 6.1 indicate that polyelectrolyte-coated gold nanorods can adsorb a 
wide variety of proteins. In addition to the variety of proteins observed, an examination of the 
molecular weights of these proteins indicated that there was no significant difference in 
adsorption based on protein size (Figure 6.2). The median molecular weight of proteins adsorbed 
onto the PSS nanorods was 46kDa while the same value for the PDADMAC coated nanorods 
was 60 kDa. These molecular weights are well within the range where intense bands were 
observed by SDS-PAGE analysis (Figure 6.1).  However, no proteins associated with either 
positive or negatively coated nanorods were detected with molecular weights at the highest sizes 
observed in the gels, suggesting that the largest bands observed may be dimers of proteins that 
were identified. 
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Figure 6.2: Molecular Weight distribution of proteins adsorbed onto polyelectrolyte-coated gold 
nanorods. Note the wider molecular weight range of proteins associated with the PDADMAC 
coated nanorods compared to proteins identified on the PSS nanorods. 
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PSS PDADMAC Both 
α-1 antitrypsin 
α-1-B glycoprotein 
anti-testosterone heavy chain 
β-2 glycoprotein 
complement C1q subunit A 
complement C1q subunit B 
complement factor H 
apolipoprotein A-II 
complement factor B 
Ig Heavy chain 
transferrin 
α-1 acid glycoprotein 
α-2 macroglobulin 
α-2-HS glycoprotein 
albumin 
biglycan 
thrombospondin 1 
 
Figure 6.3: Overlapping adsorption of proteins. While each coating, PSS or PDADMAC, had 
proteins which preferentially adsorbed, a number of proteins (6) adsorbed onto both types of 
coated nanorods. 
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Not all proteins detected were observed at equal abundance, as evidenced by the number 
of peptides identified by mass spectrometry, which corresponded to a given protein. Bovine 
albumin and α-2-HS glycoprotein were by far the most abundant proteins detected within both 
the PSS and PDADMAC samples, represented by over 300 and 100 peptides respectively. In 
addition, 37% of proteins identified bound to both negatively and positively coated nanoparticles 
(Figure 6.3). 
An examination by species of origin indicated that most of the proteins identified were of 
bovine origin, likely from the serum used in the culture media. However, biglycan and 
thrombospondin 1, are of rat origin, and therefore came from the fibroblast cells, and were found 
in the protein fractions binding to both cationic and anionic nanorods. Biglycan and 
thrombospondin 1are involved in cell-ECM or cell- cell interactions.  Biglycan is a small ECM 
proteoglycan found in most tissues and is known to influence cell-matrix interactions, and to 
modulate cardiac cell behavior by binding collagen and multiple growth factors21,22. The core 
protein of biglycan is zwitterionic at neutral pH and could associate with either a cationic or 
anionic particle; but biglyan also contains 2 carbohydrate side chains composed of sulfated 
glycosaminoglycans. The high negative charge density of these side chains is favorable for 
coordinating with the positively charged surface of PDADMAC-terminated nanorods. 
Thrombospondin 1 was also found on both the positively and negatively charged rods.  This is an 
adhesive glycoprotein that mediates both cell-cell and cell-ECM interactions by binding to 
multiple ECM proteins (including collagen, fibronectin, laminin, fibrinogen) and integrins, 
which are cell surface proteins that bind to the ECM23.   Significantly, thrombospondin 1 has a 
heparin-binding domain that would be expected to coordinate with the negatively charged 
surface of PSS-terminated nanorods. The interactions mediating adsorption of thrombospondin-1 
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to PDADMAC-terminated nanorods are unclear, and may include bridging bovine proteins. 
Overall, polyelectrolyte coated nanorods could be altering the cell-mediated matrix remodeling 
of collagen tissue constructs by adsorbing some of the major proteins – such as thrombospodin 1 
and biglycan - that the cardiac fibroblasts need to interact with both the ECM and other cells. 
Over a relatively short time span (1 h), we observed the binding of over 30 unique 
proteins from cultured media to both PSS and PDADMAC coated gold nanorods.  In 
comparison, Lundqvist et al. have studied the hard protein corona formed on both positively 
charged (amine modified) and negatively charged (carboxyl modified) polystyrene nanoparticles 
in human plasma over the same time scale13.  They observed the binding of the same groups of 
serum proteins including Ig fractions, apolipoproteins, proteins involved in the complement 
pathway, and acute phase proteins.  They also found that only a small fraction of the proteins 
identified (5-10%) were common between the charged particles for both the 50 nm and 100 nm 
polystyrene nanoparticles13.  We have a similar result in that only 37% of the proteins found on 
the nanorods are common across the two charged particles.  However, once adsorbed to the 
nanoparticles the protein’s shape, structure, and/or function may be altered due to possible 
conformational changes of the protein on the nanoparticle curved surfaces24, 25.  Therefore, not 
only are the nanoparticles adsorbing proteins the cells need for matrix remodeling; the 
nanoparticles could also be denaturing the proteins, rendering them nonfunctional even if the 
cells could access them. 
In an attempt to stop the adsorption of protein to the gold nanorods we have covalently 
bound both molecular weight 350 and 5000 PEG to the surface of the nanorods.  Figure 6.4 
details the reaction used to attach the PEG.  In short, gold nanorods are coated in a layer-by-layer 
fashion with the terminal polymer layer being PSS-MA co-polymer.  This polymer is used so 
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that after the maleic acid groups participate in amide bond formation with amine groups on the 
methoxyl PEG amine the nanorods will still be slightly charged; thereby, stabilizing them in 
solution.  The PEG is covalently attached to the PSS-MA co-polymer using EDC chemistry.  The 
zeta potential value of the nanorods after surface coating with the methoxyl PEG amine is halved 
in both cases.  TEM micrographs of both the 350 and 5000 MW PEG coated nanorods can be 
seen in Figure 6.5A-D.  Due to the size of the 5000 MW methoxyl PEG amine TEM 
micrographs of coated rods exhibit a coating around the nanomaterial (Figure 6.5A-B).  Upon 
exposure of PEG modified rods to the same type of media solutions as the polyelectrolyte 
terminated rods we see no adsorption of protein to the nanorods by gel electrophoresis.  This is a 
very promising result, which may lead to the ability to stealth rods for use in further biochemical 
studies.              
The complex network of proteins involved in cardiac fibroblast remodeling of the local 
matrix environment is still not fully understood; but it is known that biglycan levels track 
collagen levels in cardiac infarct-induced rats26, and thrombospondin 1 induces actin cytoskeletal 
reorganization. Therefore, sequestration of biglycan and thrombospondin 1 by nanorods could be 
expected to lead to changes in the cellular production of collagen and actins, as we have indeed 
observed27. 
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Figure 6.4: Process involved in the PEG coating reaction of gold nanorods with methoxy PEG 
amine. 
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Figure 6.5.  TEM micrographs of long gold nanorods (aspect ratio ~18) functionalized with (A 
& B) 5000 molecular weight PEG, (C & D) 350 molecular weight PEG. 
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6.4 Conclusion 
The results of this study offer insight into a possible mechanism by which 
polyelectrolyte-coated nanorods disrupt the matrix remodeling behavior of cardiac fibroblasts. 
The ability to bind proteins on the surface of the nanomaterials, which can modulate the matrix 
remodeling behavior of fibroblasts, suggests that the nanoparticles could serve as novel 
therapeutic agents in the regulation of wound healing. If the protein adsorption process could be 
made specific for particular proteins, one could envision regulation of cell behavior by colloidal 
nanomaterials, analogous to how fixed nanostructured substrates guide cell behavior28.  
Likewise, the use of PEG modified nanorods could ultimately provide a stealth particle that 
would allow for the study of mechanotransduction of cardiac fibroblasts in 3-D tissue culture.  
Until now we have been unable to do this due to the alteration of cell-mediated collagen 
remodeling by the nanoparticles.  Work in this area is still ongoing to determine if the PEG 
coated nanorods have the same genetic effects seen in our previous work.15 
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Chapter 7 
 
Polyelectrolyte-Coated Gold Nanorods: Effects on the Polymerization, Mechanics, and 
Cell-Mediated Remodeling of Type I Collagen  
 
7.1 Introduction 
Gold nanorods (AuNRs) are under investigation for use in biomedical applications 
including photothermal therapies1-3, imaging4-7, biochemical sensing8,9, and drug delivery10. In 
many cases the target physiologic milieu is rich in extracellular matrix (ECM), a  mixture of 
fibrillar and globular proteins, proteoglycans and glycosaminogylcans. The most abundant 
component is the structural protein collagen.  Therefore, it is likely that the performance, 
toxicity, and bioactivity of these particles will be affected by their interactions with the ECM.  
Several studies describe complex empirical relationships between nanoparticle chemistry and 
serum protein adsorption11-20, and polymeric nanomaterials have been shown to influence the 
aggregation of proteins, such as β2-microglobulin21 and amyloid β22,23.  Little is known, 
however, about how nanomaterials interact with ECM proteins. 
In serum, nanoparticles establish a dynamic protein “corona” composed of tightly bound 
and loosely bound fractions, and the surface chemistry of the particles influences the on/off rates 
of proteins20,24.  Bovine serum albumin (BSA) binds to citrate-capped gold nanospheres by 
electrostatic interactions25 and peptide-induced organization of gold nanospheres exhibits a pH-
dependent mechanism26, underscoring the importance and utility of electrostatics in predicting 
                                                
  * This chapter has been published in Biomaterials. Wilson, C. G.; Sisco, P. N.; Gadala-Maria, F. A.; Murphy, C. J.; Goldsmith, E. C. 
Biomaterials 2009, 30, 5639- 5648. (Reproduced by permission of Elsevier and co-authors) 
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and engineering nanoparticle-protein interactions.  Several groups have reported the facile 
surface modification of nanomaterials with polyelectrolyte multilayers (PEMs) composed of 
alternating layers of polyanions and polycations27-30.  By virtue of their electrostatics-based 
assembly, PEMs typically confer a net charge on the substrate and are therefore expected to 
influence protein adsorption to nanomaterials.  Indeed, the PEM composition and deposition 
conditions can alter the kinetics and extent of protein adsorption on planar surfaces31-33.  PEMs 
have demonstrated utility in regulating cell phenotype34,35 and suppressing the immune 
response36, but our understanding of how such surface modifications influence nanoparticle-
protein interactions is in the nascent stages of development. 
The effects of nanomaterials on cell-ECM interactions have received little attention to 
date.  MacDonald and colleagues showed that single-walled carbon nanotubes (SWNTs) with 
carboxylated surfaces delayed the contraction of collagen gels by smooth muscle cells37.  
Ultrafine carbon black particles (~14nm in diameter) inhibited collagen gel contraction by lung 
fibroblasts, and the effect was attributed to the particles binding fibronectin and transforming 
growth factor-β138.  Recently, we reported that AuNRs coated with PEMs terminated with 
poly(styrene sulfonate) (PSS) also inhibited cell-mediated contraction of type I collagen gels39.  
We observed that cardiac fibroblasts suspended in collagen doped with the AuNRs had lower 
expression of mRNAs for alpha smooth muscle actin and type I collagen than controls, 
indicating that the composite 3D scaffold altered the phenotype of the cells.  We also noted 
qualitative differences in the mechanical properties between control gels and collagen gels doped 
with AuNRs.  Others have demonstrated an important role for ECM stiffness in the regulation of 
progenitor, cardiac, and muscle cell phenotypes40-43, so our results led us to speculate that PSS-
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terminated AuNRs altered the assembly and mechanics of the collagen scaffold to yield the 
differences in gel contraction. 
The objective of the current study was to quantitatively examine the effects of PEM-
coated gold nanorods on the self-assembly and properties of type I collagen.  We hypothesized 
that PEM-coated AuNRs inhibited cell-mediated gel contraction by altering the stiffness and 
morphology of the collagen network.  Using PEMs of various compositions and end-groups, we 
investigated the effects of different surface chemistries on the self-assembly and cell-mediated 
contraction of collagen-AuNR composites in vitro.  Our results show that anionic nanorods 
altered the rate of polymerization, mechanical properties, and network morphology of type I 
collagen, while cationic nanorods have modest effects on these properties.  The PEM-coated 
AuNRs, however, exhibited equipotent inhibition of collagen gel contraction essentially 
independent of surface charge and chemistry, suggesting that other mechanisms of nanoparticle 
bioactivity were at play. 
 
7.2 Experimental Section 
7.2.1 Materials:  All chemicals were obtained from Sigma (St. Louis, MO), unless otherwise 
noted.  High glucose Dulbecco’s Modified Eagle’s Medium (DMEM), rhodamine phalloidin, 
4',6-diamidino-2-phenylindole (DAPI), and the stock penicillin/streptomycin solution were from 
Invitrogen (Carlsbad, CA).  
 
7.2.2 AuNR synthesis and layer-by-layer deposition of PEMs:  High aspect ratio gold 
nanorods were synthesized by a seed-mediated, surfactant-directed approach as previously 
described44,45.  Briefly, ~4 nm spherical (seed) particles were prepared via reduction of 
130 
chloroauric acid (250 µM) in water in the presence of 0.1 M ultrapure 
hexadecyltrimethylammonium bromide (CTAB) by 0.01 M ice-cold sodium borohydride.  After 
15 min., the seed particles were diluted 1000-fold in a solution containing 250 µM chloroauric 
acid, 0.1 M CTAB, and 500 µM ascorbic acid and allowed to react overnight at room 
temperature.  The supernatant was decanted, and the remaining particles were resuspended in 18 
MΩ/cm water.  These reactions yielded polydisperse populations of nanoparticles, with the 
predominant morphologies being rods of length 392 ± 93 nm and width 22 ± 3 nm.  The 
concentration of gold in preparations of AuNRs was determined by inductively coupled optical 
emission spectroscopy. 
A positively charged CTAB bilayer was present at the surface of the as-prepared AuNRs 
and served as the basis for layer-by-layer deposition of polyelectrolytes.  Assembly of PEMs on 
the AuNRs was performed as previously described29.  Briefly, AuNRs were first incubated with 
1.7 mg/mL PSS (70 kDa) or poly(acrylic acid) (PAA, 15 kDa) in 1 mM NaCl for 30 min at room 
temperature. The rods were then washed by centrifugation [4000 relative centrifugal force 
(RCF), 5 min.] and resuspended in 18 MΩ/cm water.  PSS-and PAA-coated rods were then 
incubated with 1.7 mg/mL poly(diallyldimethylammonium) chloride (PDADMAC, <100 kDa) or 
poly(allylamine) hydrochloride (PAH, 15kDa), respectively, for 30 min at room temperature.  
After washing as described above, portions of PDADMAC- and PAH-coated AuNRs were 
incubated with 1.7 mg/mL PSS or PAA, respectively, for 30 min at room temperature and 
washed.  Multilayer assembly was monitored by measurement of the zeta potential (ζ) of the 
AuNRs in 18 MΩ/cm water (ZetaPALS, Brookhaven Instruments Corp., Holtsville, NY).  The 
zeta potential, an approximation of the effective surface charge, reversed polarity with the 
addition of each polyelectrolyte layer, and the final zeta potential for each preparation of AuNRs 
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is given in Table 7.1. Based on previous work in our lab29, we estimate that the 3-layer coatings 
used in this study added 4-5 nm to both the radius and the length of the as-prepared AuNRs. 
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Figure 7.1. Polyelectrolyte multilayer assembly on the surfaces of AuNRs and the effects of 
polyelectrolyte-coated AuNRs on the self-assembly of type I collagen. (A) Schematic of gold 
nanomaterial surfaces presenting the CTAB bilayer and the 2-layer (for polycation-terminated 
AuNRs) or 3-layer (for polyanion-terminated AuNRs) polyelectrolyte coatings. Layer 
thicknesses are not drawn to scale. (B) Cell-free turbidity assays revealed charge-dependent 
perturbations in the polymerization of collagen doped with polyelectrolyte-coated AuNRs. Plot 
legend indicates the identity and polarity of the terminal polyelectrolyte for each PEM-coated 
AuNR. Data are mean ± S.D. with n = 3 from a representative experiment. Absorbances were 
corrected by subtraction of the initial (t = 0) absorbance. (C) A kinetic parameter, 
Δτ = τ50 − τ50,control, and the equilibrium absorbance, Aeq, were determined from the 
polymerization curves. AuNR surfaces terminated with negatively charged polyelectrolytes had 
negative Δτ and lower Aeq than controls, whereas AuNRs with a positively charged surface had 
positive Δτ. Aeq values were normalized by control values. Data are mean ± S.D. with n = 8 from 
3 independent experiments. * indicates p < 0.05 vs. controls. 
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Table 7.1. Zeta potentials (ζ) of as-prepared and polyelectrolyte-coated gold nanorods 
suspended in 18 MΩ/cm water. The label of each AuNR preparation used in the figure legends is 
also given. 
 
Polyelectrolyte multilayer 
composition 
Figure legend 
label 
ζ (mV) 
None AuNR +44.14 ± 1.35 
PSS–PDADMAC–PSS AuNR–PSS −44.08 ± 1.25 
PSS–PDADMAC 
AuNR–
PDADMAC 
+56.26 ± 1.06 
PAA–PAH–PAA AuNR–PAA −28.37 ± 1.05 
PAA–PAH AuNR–PAH +52.63 ± 1.64 
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7.2.3 Turbidity Assays:  We used a well established turbidity assay46,47 modified for a 
microplate reader to examine the effects of AuNRs on the polymerization of type I collagen.  
Acid-solubilized bovine type I atelocollagen from a commercial source (3.1 mg/mL, Inamed, 
Santa Barbara, CA) was neutralized on ice with 0.2 N 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), pH 9.0 and 10-fold concentrated phosphate buffered 
saline (PBS) in the volumetric ratio of 8:1:1.  The neutralized collagen was then mixed with as-
prepared AuNRs (no PEM), or PSS-, PDADMAC-, PAA-, or PAH-terminated AuNRs.  The 
collagen-AuNR solutions were vortexed briefly, sonicated for 30 s, and kept on ice for no more 
than 10 min prior to polymerization.  The final concentrations of collagen and gold were 2.2 
mg/mL (~22 µM) and 337 ng/mL (~200 pM in particles), respectively.  Portions of each solution 
(100 µL) were moved to the wells of a microplate in duplicate or triplicate for each experiment.  
The microplate was then moved to a temperature-controlled (37 °C) microplate reader (Bio-Rad, 
Hercules, CA) and the absorbance (λ = 400 nm) was measured every 60 s for 1 h.  Absorbances 
were corrected by subtraction of the initial (t = 0) absorbance, to account for the extinction due to 
the nanoparticles.  Kinetic parameters, including τ50 and Δτ, and the equilibrium absorbance, Aeq, 
were calculated from each turbidity curve to quantify AuNR-induced changes in polymerization.  
Aeq was calculated as the mean absorbance over the last 5 minutes of the experiment.  τ50 was 
defined as the time for each sample to reach 50% of its Aeq, and Δτ was calculated as the 
difference between τ50 of the sample and the mean τ50 of controls within each experiment.  Aeq 
values were normalized by dividing by the average Aeq of controls within each experiment.  
Computation of the self-assembly parameters was performed using Excel spreadsheet software 
(Microsoft, Redmond, WA). 
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7.2.4 Rheology:  The effects of AuNRs on the mechanical properties of cell-free type I collagen 
gels were examined by dynamic torsional shear tests.  Tests were performed on an RFS II Fluid 
Spectrometer (Rheometric Scientific, Piscataway, NJ) with a 25 mm parallel plate measurement 
geometry and a temperature-controlled lower plate, and the data were analyzed with Rhios 
version 4.2.2 software (Rheometric Scientific).   
 Type I collagen gels with and without AuNRs were prepared as described above for the 
turbidity assays, and 285 µL of ice-cold neutralized collagen solution was placed on the lower 
plate at a temperature of ~14 °C.  The upper plate was lowered to a gap of 500 µm, and low 
viscosity mineral oil was applied around each sample to minimize evaporation.  The complex 
shear modulus (G*) was measured for 1 h as the temperature of the lower plate was increased to 
37 °C and the sample polymerized; during this time each sample underwent sinusoidal 
deformation at 1 rad/s and 2% strain.  These tests also afforded computation of the phase angle, 
δ, between the applied strain wave and measured stress wave.  The tangent of the phase angle, 
tan δ, was calculated as the ratio of the loss modulus to storage modulus (G''/G') and was used to 
describe the viscoelastic behavior of each material.  Following phase transition and equilibration 
for 1 h at 37 °C, each sample was subjected to sinusoidal strain (10 rad/s) over a range of strains 
(γ = 1-100%) to examine the strain-stiffening behavior characteristic of polymerized type I 
collagen48. 
 
7.2.5 Cell isolation and culture:  Cardiac fibroblasts were isolated from 4 day old neonatal rats 
as previously described49 and according to a protocol approved by the University of South 
Carolina IACUC.  Briefly, whole hearts were aseptically harvested from the animals, rinsed and 
minced in Krebs-Ringer bicarbonate buffer, and digested with 100 U/mL collagenase 
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(Invitrogen). The digests were mechanically dissociated by passing through a 14 gauge cannula 
and moved to T75 flasks for 2 h in a standard tissue culture incubator (37 °C, 5% CO2, ~95% 
relative humidity), after which a fibroblast-rich population of cells had adhered to the flasks.  
Cells were expanded through passage 2 or 3 in culture medium composed of DMEM 
supplemented with 10% newborn bovine serum, 5% fetal bovine serum, 100 U/mL penicillin G, 
100 µg/mL streptomycin, and 10 µg/mL gentamicin (Invitrogen).  Prior to suspension in 3D 
collagen or collagen-AuNR gels, cells were rinsed with Moscona’s saline, trypsinized [0.25% 
trypsin with 1 mM ethylenediaminetetraacetic acid (EDTA), Invitrogen] for 3 min in a tissue 
culture incubator, quenched with serum-containing culture medium, centrifuged, and 
resuspended in serum-free medium composed of DMEM with 0.5% BSA, 1mg/mL insulin, 0.55 
mg/mL transferrin, 0.5 µg/mL sodium selenite, 82 µg/mL ascorbic acid 2-PO4, and antibiotics as 
listed above.  Cell number and viability were determined with a hemocytometer by counting and 
erythrosin B exclusion. 
Neutralized collagen and collagen-AuNR composites were prepared as described above 
for the turbidity experiments.  Cardiac fibroblasts were suspended in the neutralized collagen 
solutions at a final cell density of 200,000 cells/mL, and the constructs were cast in the wells of a 
24-well plate (500 µL/well) preadsorbed with 5% BSA.  The plates were moved to a tissue 
culture incubator where the constructs were allowed to polymerize for 1 h.  The constructs were 
then detached from the surface of the wells and floated in serum-free culture medium.  Serum-
free medium was used to minimize the effects of exogenous growth factors and fibronectin on 
AuNR-collagen and AuNR-cell interactions.  Collagen gel contraction over 48 h was quantified 
by analysis of images captured with a digital camera (Canon USA, Lake Success, NY) using 
ImageJ software50.  The culture medium was collected and replaced every 24 h.  After 48 h, 
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some constructs were incubated with Alamar Blue (Invitrogen) according to the manufacturer’s 
instructions for another 24 h.  Some 8 h and 24 h constructs were fixed in 4% paraformaldehyde 
overnight at 4 °C for confocal microscopy, while additional 24 h constructs were fixed overnight 
in 2.5% glutaraldehyde, 1% tannic acid, and 1% OsO4 in 0.1 M sodium cacodylate for 
transmission electron microscopy (TEM). 
 
7.2.6 Darkfield, confocal, and transmission electron microscopy:  The morphology of the 
collagen network in the absence and presence of AuNRs was examined through dark field 
microscopy of thin films.  Darkfield microscopy also has demonstrated utility in the high-
resolution localization of AuNRs1,4.  Collagen and collagen-AuNR composites were prepared as 
described above for the turbidity assays and diluted with ice-cold PBS to a final concentration of 
0.5 mg/mL collagen; the molar ratio of collagen to AuNRs was similar to that of the samples 
used in turbidity assays, rheologic measurements, and culture experiments.  The films were 
prepared by applying a small volume of sample (~100 µL) to the surface of an uncharged 
microscope slide and then placing a 22 mm x 40 mm x 1.5 mm coverslip over the sample.  The 
slides were warmed in a tissue culture incubator for 30 min at 37 °C, and the coverslips were 
sealed with nail polish prior to imaging.  The polymerized collagen networks were imaged 
through 20x air darkfield optics on a Nikon E600 with a mercury vapor lamp light source 
(EXFO, Quebec, Canada).  Images were captured with a Spot Insight camera and Spot software 
(both from Diagnostic Instruments, Sterling Heights, MI), and the gamma values were manually 
adjusted to enhance contrast in ImageJ. 
Constructs fixed for confocal microscopy were rinsed with PBS, permeabilized with 
0.01% Triton X-100/0.1 M glycine/PBS for 30 min at room temperature, and stained whole 
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mount with 1 U/mL rhodamine-phalloidin and 1 µg/mL DAPI in PBS for 4 h at room 
temperature.  The constructs were rinsed three times with PBS, mounted in 1 mg/mL 1,4-
diazabicyclo[2.2.2]octane in 3:1 glycerol:PBS (v/v), and set in CoverWell chambers (Electron 
Microscopy Sciences, Hatfield, PA) on microscope slides.  The constructs were optically 
sectioned on a Zeiss 510LSM confocal laser scanning microscope with 40x and 63x oil 
immersion objectives.  Rhodamine phalloidin and DAPI were excited by 543 nm and 405 nm 
lasers, respectively, and detected via appropriate emission filters.  The collagen network and 
AuNRs were detected by confocal reflectance microscopy51 with the 488 nm and 633 nm laser 
lines.  The collagen efficiently reflected 488 nm light, whereas the AuNRs efficiently reflected 
both 488 nm and 633 nm light, and this difference afforded distinction between the two 
components of the scaffold material.  The 488 nm reflectance tracks in each image were post-
processed using an anisotropic diffusion algorithm52 in ImageJ to reduce noise. 
Constructs fixed for TEM were dehydrated in graded alcohols, embedded in Polybed 812 
in acetonitrile, and sectioned at 110 nm on a Leica Ultracut R.  Each section was placed on a 
copper grid, stained with Hanaichi’s lead stain53, dried at room temperature, and imaged on a 
JEOL JEM-200CX TEM at 120kV.  
 
7.2.7 Statistics:  Turbidity assays and culture experiments were examined in 3 independent 
experiments, with 2-3 replicates in each experiment, and rheology tests were performed on 3 
samples per condition.  The darkfield, confocal, and TEM images are representative of 4-5 fields.  
Data were analyzed by the general linear model and Dunnett’s post-hoc comparisons using 
Minitab version 15 (State College, PA), and differences were deemed significant for p < 0.05. 
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7.3 Results 
7.3.1 Polymerization of collagen in the absence and presence of AuNRs  We examined the 
self-assembly of collagen in the absence and presence of PEM-coated AuNRs by turbidity 
assays.  Neutralized type I collagen exhibits a sol-gel phase transition at ~37 °C characterized by 
a lag phase in which monomers coalesce into nuclei and a growth phase during which nuclei 
undergo anisotropic longitudinal and lateral accretion54,55.  During the growth phase, the turbidity 
of the collagen solution increases as the growing fibrils increasingly scatter and absorb light. The 
diffusion and concentration of monomer eventually become limiting, fibril formation (i.e., 
fibrillogenesis) slows, and the optical density of the solution approaches a plateau (Aeq).   
In our experiments, controls composed of neutralized collagen in the absence of AuNRs 
exhibited a lag phase of approximately 5 min and a τ50 of approximately 12 min (Figure 7.1A).  
The addition of AuNRs terminated with negatively charged polyelectrolytes, including PSS and 
PAA, accelerated the self-assembly of collagen whereas cationic particles, terminated with 
PDADMAC or PAH, delayed fibrillogenesis.  Quantification of the kinetic and equilibrium 
turbidity parameters revealed statistically significant reductions in τ50 (indicated by negative Δτ) 
and Aeq with the addition of PSS- or PAA-presenting AuNRs compared to controls (Figure 
7.1B), and PAA-terminated AuNRs accelerated fibrillogenesis more potently than PSS-
terminated AuNRs.  In contrast, AuNRs with positively charged end groups significantly 
increased τ50 over that of controls but had no effect on Aeq.  The addition of as-prepared AuNRs 
presenting the positively charged CTAB end group had no significant effects on τ50 or Aeq (not 
shown).  These results indicate that PEM-coated AuNRs influenced collagen self-assembly in 
charge- and end-group-dependent manners, and suggest that polyanionic surface chemistries 
promoted fibril nucleation in collagen-AuNR composites.   
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7.3.2 Rheology of collagen and collagen-AuNR composites  The mechanical properties of 
collagen and collagen-AuNR composite gels were examined by rheologic methods during and 
following polymerization.  A time sweep during which oscillatory torsion was applied to a 
warming sample revealed that controls exhibited an increase in the complex shear modulus (G*) 
beginning approximately 10 min after the start of the test and within 1 min of the plate reaching 
37 °C (Figure 7.2A).  Consistent with the results of the turbidity assays, collagen doped with 
AuNRs terminated with PSS or PAA exhibited a reduced lag time between the start of the test 
and the increase in G* as compared to controls.  In contrast, addition of AuNRs terminated with 
PDADMAC modestly delayed the increase in G*.  PAH-terminated and as-prepared AuNRs had 
no significant effects on the change in G* associated with the collagen phase transition.   
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Figure 7.2. The dynamic shear properties of type I collagen doped with various preparations of 
AuNRs. (A) Low amplitude oscillatory torsion tests were performed on neutralized collagen gels 
as they underwent a temperature-dependent phase change. Gels containing PSS- or PAA-
terminated AuNRs polymerized more rapidly than controls, whereas polycation-terminated 
AuNRs modestly delayed increases in G*. The detection limit of the instrument was G* ≈ 2 Pa in 
these experiments. (B) After 1 h at 37 °C, collagen gels doped with PSS- or PAA-functionalized 
AuNRs had lower tan δ and higher G* than controls (p < 0.05). (C) The AuNR-induced 
differences in G* were detected over a range of shear strains. Data are mean ± S.D. with n = 3. 
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AuNR-induced differences in the mechanical properties of the collagen were evaluated in 
terms of the equilibrium G* and tan δ, calculated as the means of these parameters over the last 5 
min of the time sweep (Figure 7.2B).  Collagen doped with PSS- or PAA-terminated AuNRs had 
significantly higher G* (+94% and +228%, respectively) and lower tan δ (-45% and -42%, 
respectively) than controls, indicating that these composite materials are stiffer and more elastic 
(i.e., capable of storing kinetic energy) than controls.  In contrast, collagen doped with as-
prepared or polycation-terminated AuNRs had equilibrium G* and tan δ values statistically 
similar to controls. 
Type I collagen and other biopolymers, such as fibrin and several cytoskeletal proteins, 
exhibit strain-stiffening behavior 48,56,57, and we implemented strain sweeps to explore the effects 
of PEM-coated AuNRs on this property of polymerized collagen (Figure 7.2C).  In our 
experiments, the G* of control gels was steady for γ = 1-10%, increased for strains of 10~73%, 
and decreased at higher strains.  Collagen gels doped with PAA- or PSS-terminated AuNRs had 
higher G* values than controls for most strains, but otherwise exhibited similar strain-stiffening 
behavior to controls.  Polycation-terminated AuNRs had G* values and strain-stiffening behavior 
similar to controls.  Interestingly, collagen containing PAA-terminated AuNRs had a 
significantly lower failure strain, defined as the strain at which the peak G* was measured, than 
controls (~31% vs. ~63%, p < 0.05), and there was a trend for as-prepared AuNRs to have a 
similar effect  (p < 0.1).  These results indicate that PEM-coated AuNRs do not substantially 
perturb the strain stiffening behavior of type I collagen, but suggest that the nanomaterials 
adversely affect the failure properties of collagen gels. 
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7.3.3 Collagen network morphology  The morphology of collagen fibrils and the pore space 
between them in 3D gels and thin films were qualitatively examined using confocal reflectance 
and darkfield microscopy, respectively (Figure 7.3).  AuNRs and aggregates thereof were also 
readily detected by these methods as previously described by our group and others 4,6,39,58,59.   
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Figure 7.3. The morphology of cell-free collagen and collagen–AuNR composites. Upper panels 
are representative images of 3D constructs 100 µm from the gel surface captured via confocal 
reflectance microscopy (488 nm laser line, optical section thickness 800 nm). Lower panels are 
images of thin films captured by darkfield microscopy. In images of collagen doped with AuNR–
PSS, upward arrowheads point to aggregates of AuNRs and downward arrowheads point to 
individual AuNRs. 
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Optical sections of 3D gels approximately 100 µm from the gel surface (Figure 7.3, upper 
panels) illustrate the meshwork of fibrils and high porosity characteristic of polymerized 
collagen.  Collagen gels doped with as-prepared AuNRs had a network morphology similar to 
that of controls with intense points of reflected light indicative of AuNRs and their aggregates.  
As we have observed in previous studies39, the addition of PSS-coated AuNRs did not 
substantially alter the collagen network morphology, although large clusters of nanomaterials 
were identified by confocal reflectance in the midsubstance and on the surfaces (not shown) of 
the 3D gels.  PAA-terminated AuNRs were found to be dispersed throughout the 3D gels as 
individual and/or relatively small aggregates closely associated with fibrils and fibril-fibril 
junctions.  Collagen gels prepared with PDADMAC- or PAH-terminated AuNRs had network 
morphologies similar to controls, and both varieties of polycationic AuNRs were dispersed as 
individual particles or small aggregates in the collagen.  For all AuNR-doped gels, the 
nanomaterials and aggregates thereof were detected primarily along, within, or at the junction of 
collagen fibrils.  These results show that AuNRs have subtle effects on the micro-scale 
organization of collagen in 3D gels, but suggest that the nanomaterials are localized in the 
insoluble compartment of the network, intimately associated with the collagen fibers. 
Analysis of thin collagen films by darkfield microscopy revealed striking differences in 
network morphology by the addition of AuNRs (Figure 7.3, lower panels).  Controls exhibited a 
fine meshwork of fibrils amid a diffuse background arising from out-of-plane fibrils.  Films 
containing as-prepared AuNRs had lower background than controls, and, as in the 3D gels, the 
AuNRs were dispersed throughout the film as individual particles or small aggregates.  Films 
prepared with PSS-terminated AuNRs formed large, heterogeneous aggregates, and PAA-
terminated AuNRs induced formation of similar, although generally smaller, aggregates.  
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Interestingly, fibrils of collagen extended radially from the surfaces of the aggregates.  In 
contrast, films prepared with PDADMAC- or PAH-terminated AuNRs exhibited collagen 
network morphologies qualitatively similar to controls.  These data suggest that polyanion-
terminated AuNRs promote nucleation (i.e., aggregate formation) in thin films of type I collagen. 
 
7.3.4 Gel contraction and cell morphology in collagen and collagen-AuNR composites  We 
used gel contraction culture studies to quantitatively compare the cell-mediated remodeling of 
collagen and collagen-AuNR composites.  Control constructs, composed of AuNR-free collagen 
seeded with neonatal cardiac fibroblasts, contracted to approximately 46% of the initial gel area 
over 48 h (Figure 7.4A).  Constructs doped with as-prepared AuNRs exhibited minimal 
contraction over the same period, and PEM-coated AuNRs reduced contraction by 13-28%.  The 
kinetics of contraction were similar between controls and composites containing PEM-coated 
AuNRs.  AuNR-induced differences in gel contraction after 48 h were statistically significant for 
all groups except the PAH-terminated AuNRs (Figure 7.4B). 
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Figure 7.4. The contraction of collagen and collagen–AuNR scaffolds by cardiac fibroblasts. (A) 
Contraction of free-floating collagen gels was measured over 48 h. Data are means with n = 8–9 
from 3 independent experiments; error bars are omitted for clarity. (B) After 48 h, gels 
containing AuNRs were contracted less than controls. Data are means + S.D. (C) As-prepared 
AuNRs, but not polyelectrolyte-coated AuNRs, significantly reduced mitochondrial activity as 
measured by the Alamar Blue Assay. Data are means + S.D. with n = 6 from 2 independent 
experiments. For B and C, * indicates p < 0.05 vs. controls. 
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The contribution of cytotoxicity in the gel contraction studies was examined using the 
Alamar Blue assay.  The reactive component of Alamar Blue, resazurin, undergoes reduction to a 
different-colored product in the presence of viable cells.  We observed a significant decrease in 
resazurin reduction in constructs doped with as-prepared AuNRs, indicating that these 
nanomaterials are cytotoxic (Figure 7.4C); previous work in our lab has shown that free CTAB 
in the AuNR preparation is responsible for this cytotoxicity60.  In contrast, AuNRs terminated 
with PSS, PDADMAC, PAA, or PAH exhibited resazurin reductions statistically similar to that 
of controls, suggesting that AuNR-induced reductions in collagen gel contraction were not due to 
cytotoxicity. 
We examined cell spreading in the collagen and collagen-AuNR composite constructs by 
confocal microscopy.  After 8 h, an early time by which substantial inhibition of gel contraction 
was observed, cells in constructs doped with PEM-coated AuNRs were spread similar to cells in 
control gels (Figure 7.5, top row).  Cells seeded with as-prepared AuNRs had failed to spread by 
this time (not shown), as indicated by the round shape of most cells and consistent with the 
cytotoxicity noted in these cultures by the Alamar blue assay .  After 24 h, cells in control gels 
and gels doped with poylelectrolyte-coated AuNRs were again similarly well spread (Figure 7.5, 
middle row).  Using confocal reflectance microscopy with the 633 nm laser line, we observed 
PEM-coated AuNRs in the peri- and/or intra-cellular compartments and in the interstitial 
compartment among collagen fibrils (Figure 7.5, bottom row).  These results indicate PEM-
coated AuNRs do not alter superficial aspects of cell-collagen interactions (e.g., spreading), and 
that the AuNRs are in close proximity to the cell surface.   
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Figure 7.5. The morphologies of cells embedded in collagen and collagen–AuNR composites. 
The top and middle row panels are representative images of cells after 8 h and 24 h of culture, 
respectively. Actin was stained with rhodamine–phalloidin (red) and nuclei were stained with 
DAPI (blue). The bottom row panels are representative images of cells after 48 h of culture. 
Actin and nuclei were stained as in upper panels. Confocal reflectance images reveal the 
morphology of the collagen network (green, 488 nm) and the locations of AuNRs and their 
aggregates (white, coincident reflection of 488 nm and 633 nm). 
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7.3.5 TEM localization of AuNRs in collagen and cells  Images of AuNR-collagen and AuNR-
cell interactions were generated by TEM of constructs cultured for 24 h; we focused on the 
interactions of PSS- and PAA-terminated AuNRs due to  their potent effects on collagen self-
assembly, mechanics, and cell-mediated gel contraction.  Both PSS- and PAA-terminated 
AuNRs were observed as individual particles and as aggregates surrounded by disorganized 
collagen (Figure 7.6A, B).  In addition, polyanion-terminated AuNRs were detected within cells 
as individual particles and aggregates (Figure 7.6C, D).  These results indicate that the AuNRs 
became entrained within the collagen and were taken up by the fibroblasts via endocytosis. 
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Figure 7.6. TEM images of polyanion-terminated AuNRs localized in the collagen matrix and in 
intracellular compartments. PSS-terminated (A) and PAA-terminated AuNRs (B) were often 
surrounded by disorganized collagen. After 24 h of culture, the AuNRs were detected as single 
particles (C, indicated by “v”) and as aggregates (D) within the cells. 
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7.4 Discussion 
AuNRs have great potential for use in high resolution imaging of tissues and cells6,7, 
biochemical sensing9, and photothermal therapies1,3,5, but questions remain about how proteins 
and cells interact with these nanomaterials.  Indeed, the toxicity and in vivo fate of nanoparticles 
are of increasing interest in the burgeoning fields of nanomedicine and nanobiotechnology61.  We 
recently reported that PSS-terminated AuNRs inhibited cardiac fibroblast-mediated contraction 
of type I collagen gels in vitro and that this effect was in part due to reduced expression of genes 
associated with the contractile myofibroblast phenotype39.  The current study represents an initial 
approach to elucidating the mechanisms by which the AuNRs elicited these differences in 
collagen remodeling and cell phenotype. 
PEM-coated AuNRs terminated with PSS or PAA potently accelerated the 
polymerization of type I collagen.  Natural polyanions in solution, including sulfated 
glycosaminoglycans and sodium alginate, are known to influence the kinetics of polymerization 
of type I collagen gels62-66.  There are few reports describing the effects of synthetic polyanions 
on collagen, but high molecular weight PAA (Mw ~ 150 kDa) did not interact with type I 
collagen in solution at physiologic pH and salt concentration67, whereas PSS (Mw ~ 1.4 MDa) 
had dose-dependent effects on the conformation of denatured collagen (gelatin)68.  In our 
experiments the PAA- and PSS-terminated AuNRs significantly reduced the lag phase of 
polymerization, indicating that these nanomaterials promoted aggregation of collagen monomers 
(nucleation of fibrils).  Polymeric nanoparticles induced aggregation of the serum proteins β2-
microglobulin and amyloid-β in vitro, and the effect was attributed to recruitment of monomers 
to the particle surface via electrostatic interactions21-23.  Collagen monomers contain numerous 
charged residues69 capable of interacting with the multivalent PEM coatings on the 
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nanomaterials used in this study and confocal and electron microscopy confirmed that the PSS- 
and PAA-terminated AuNRs interacted directly with the collagen.  In addition, darkfield images 
of collagen-AuNR thin films revealed that the polyanion-terminated AuNRs induced formation 
of large, stable aggregates of collagen.  These results support the hypothesis that polyanion-
terminated AuNRs interact directly with collagen monomers to accelerate the aggregation and 
polymerization of collagen in vitro.  Such interactions may be significant in the contexts of 
delivering these nanomaterials to collagen-rich tissues (e.g., fibrotic myocardium) or to collagen-
synthesizing cells such as fibroblasts. 
Collagen gels doped with PSS- or PAA-terminated AuNRs were significantly stiffer than 
controls under oscillatory shear.  The shear stiffness of collagen gels has previously been shown 
to be sensitive to the presence of the biopolyanion chondroitin sulfate70,71, and collagen-rich 
tissues with high concentrations of glycosaminoglycans (e.g., articular cartilage) exhibit shear 
properties dependent on the concentration of immobilized polyelectrolytes72-74.  Using the 
measured dimensions of the AuNRs and calculated polymer chain lengths, we estimated the bulk 
concentrations of “available” polyelectrolyte (polyelectrolytes in the outermost layer of the 
nanomaterial surface coatings) in our collagen-AuNR solutions to be 1-5 µg/mL, and we 
experimentally measured the available PSS on PSS-terminated AuNRs to yield bulk PSS 
concentrations of ~1.3 µg/mL (data not shown).  At such apparently low concentrations of 
polyelectrolyte we would expect osmotic swelling effects and electrostatic interactions between 
polyelectrolyte chains to contribute little to the bulk mechanical properties of the collagen gel75.  
It is likely, however, that within aggregates of PAA- or PSS-terminated AuNRs – which were 
readily observed by confocal and darkfield microscopy – the local concentration of 
polyelectrolytes was substantially higher than the bulk concentration and that these pockets of 
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high charge density were responsible for changes in the bulk shear properties of the collagen 
gels.  Such charged structures may locally alter the interactions between collagen fibrils and/or 
the network mesh size (i.e., distance between fibril-fibril junctions) to alter the mechanics of the 
gel48.  Indeed, there was evidence of increased mesh size in the thin films of collagen gels doped 
with polyanion-terminated AuNRs.  Further studies are necessary to resolve the biophysical 
origin of AuNR-induced stiffening of the collagen. 
PAA-terminated AuNRs had more potent effects on collagen polymerization and 
mechanics than PSS-terminated AuNRs.  In addition, collagen gels doped with PAA-terminated 
AuNRs uniquely exhibited a lower failure strain than controls.  PAA is a weak polyanion (pKa ~ 
5) whereas PSS is a strong polyanion (pKa ~ 1), and the ζ-potential of the PAA-terminated 
AuNRs was substantially lower than that of the PSS-terminated AuNRs.  We speculate that the 
distinct biophysical properties of the carboxylate and sulfonate functional groups on these 
polyelectrolytes contributed to different affinities of PAA- and PSS-terminated AuNRs for 
collagen monomers and/or aggregates.  Further work is ongoing to elucidate the origin of the 
differences between PAA- and PSS-terminated AuNRs and their effects on collagen assembly 
and mechanics, and our results underscore the important role that surface chemistry plays in 
determining particle-protein interactions. 
PEM-coated AuNRs inhibited cell-mediated contraction of collagen gels independent of 
PEM composition.  Whereas PSS- and PAA-terminated AuNRs inhibited contraction in part by 
increasing the stiffness of the collagen, it is less clear how PDADMAC- and PAH-terminated 
AuNRs inhibited contraction since these nanomaterials had no detectable effects on the 
mechanical or morphological properties of the collagen scaffold.  It is possible that the 
polycation-coated AuNRs were preferentially internalized by the cardiac fibroblasts in our 
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studies and that intracellular accumulation of the AuNRs inhibited cell contractility.  In MDCK 
and HeLa cells, polymeric nanoparticles with a cationic surface charge were more readily 
endocytosed than similar particles with an anionic surface charge76,77.  Previous work by our 
group has also shown that PAH-terminated AuNRs accumulated within HT-29 colon cancer cells 
to a greater extent (by nearly 10 fold) than PAA-terminated AuNRs 60.  These charge effects may 
be attributed to electrostatic interactions between the particle surface and the negatively charged 
phospholipids of the cell membrane.  Little is known, however, about the functional implications 
of intracellular nanoparticle accumulation and transport. Surface chemistry-dependent 
differences in AuNR uptake, particularly in 3D culture environments, will benefit from future 
studies. 
The effects of PEM-coated AuNRs on cell-matrix interactions require further 
investigation. Several recent reports show that cells are sensitive to nanoscale features of the 
ECM.  Spherical albumin nanocarriers functionalized with fragments of fibronectin enhanced de 
novo deposition of fibronectin by human fibroblasts78,79.  Zinc oxide nanorods inhibited cell 
adhesion and lamellapodia formation in 2D cell cultures80, and nanoscale clustering of the 
adhesion ligand RGD regulated cell adhesion, motility, and response to substrate stiffness 81,82.  
AuNRs were readily detected at and near the cell surface in our experiments; it is possible that 
the nanomaterials altered the availability of collagen in sufficient proximity to cell surface 
receptors to alter ligand binding or clustering and downstream signaling events.  
Type I collagen is an abundant protein that is just one important candidate for evaluating 
nanoparticle-protein interactions.  Other soluble and insoluble factors are also likely to interact 
with PEM-coated AuNRs in our culture system. Basic fibroblast growth factor (bFGF) and 
fibronectin, for example, contain heparin binding domains83,84 that are rich in acidic residues and 
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are likely to bind polyanions immobilized at the surface of the nanomaterials.  There is precedent 
for this concept, as the polyanions alginate and alginate-sulfate were recently shown to have 
affinities for growth factors equal to or greater than those of heparin85,86.  Significantly, 
fibronectin assumes different conformations when bound to PEMs terminated with polyanions 
and polycations 31, suggesting that interaction with PEM-coated AuNRs alters the activity and/or 
availability of fibronectin in a surface chemistry-dependent manner.  In addition, both bFGF and 
fibronectin regulate the cell-mediated remodeling and contraction of collagen scaffolds 87-92.  
Thus, the biophysical properties of PEM-coated AuNRs are favorable for binding numerous 
soluble and insoluble proteins in the ECM, and such interactions are likely to influence the 
physiologic effects of the AuNRs both in vitro and in vivo.    
 
7.5 Conclusions 
The results of this study provide evidence that polyanion-terminated AuNRs interact 
directly with type I collagen to alter the polymerization and mechanical properties of this ECM 
component.  Both polyanion- and polycation-terminated PEMs improved the biocompatibility of 
AuNRs and inhibited contraction of collagen gels by cardiac fibroblasts in vitro.  The effects of 
the AuNRs on collagen contraction and mechanical properties may be therapeutic in the context 
of limiting scar formation in the infarcted heart, but further studies are required to elucidate the 
mechanisms by which these nanomaterials exert their effects on cells. 
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Chapter 8 
 
Glycosaminoglycan-Functionalized Gold Nanorods: Interactions with Cardiac Cells and 
Type I Collagen  
 
8.1 Introduction 
 Gold nanoparticles are of great interest for biochemical detection and imaging, due to 
their intense optical absoprtion and scatteting properties1-3.  While there are examples of gold 
nanoparticles as therapeutics at least at the cellular level4-6, concerns about the unintended 
consequences of nanomaterial introduction into a living system have been raised7,8. Several 
groups have demonstrated the potential for nanomaterials to alter cell behavior4,9-11, and we 
reported that gold nanorods presenting a synthetic polyanion, polystyrene sulfonate (PSS), on 
their surfaces inhibited the cell-induced contraction of a three-dimensional type I collagen 
scaffold by neonatal cardiac fibroblasts12. The mechanisms by which nanomaterials elicit 
changes in cell function are largely unknown, but cell uptake of inorganic and organic 
nanoparticles is regulated by particle size and surface charge13,14, and the exchange of 
adsorbed proteins on nanoparticle surfaces is in part governed by particle size and surface 
chemistry15,16. Interestingly, nanoparticles can also perturb protein/polypeptide fibril 
assembly by promoting or inhibiting nucleation17-21. 
 Sulfated glycosaminoglycans (sGAG) including heparin and chondroitin sulfate (CS) 
are natural polyanions that participate in a variety of morphogenic events during 
                                                
  * This chapter has been published in the Journal of Materials Chemistry. Wilson, C. G.*; Sisco, P. N.*; Goldsmith, E. C.; Murphy, C. J. J. 
Mater. Chem. 2009, 19, 6332-6340. * Equal Contributors (Reproduced by permission of The Royal Society of Chemistry and co-authors) 
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development and disease. Heparin has the highest charge density of any biological 
molecule22, and CS is the most prevalent sGAG in adult connective tissues23. The 
fundamental units of sGAG are disaccharides composed of a hexuronic acid or hexose joined 
with a hexosamine through a glycosidic linkage, and the polyanionic character of most sGAG 
arises from sulfation of the disaccharides (Figure 8.1A). A range of protein-binding and 
biophysical properties are acheived through variations in the degree and patterns of sulfation. 
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Figure 8.1 (A) Schematic describing cell-free collagen polymerization assays. Ice-cold 
neutralized type I collagen was polymerized at 37 °C in the absence or presence of gold 
nanoparticles (GNPs) in the wells of a 96-well plate. The absorbance ( = 400 nm) of each 
solution was measured over time and increased as the collagen underwent nucleation and fibril 
growth during polymerization. Equilibrium absorbance (Aeq) and a time constant (50) were used 
to characterize the collagen polymerization. (B) Schematic describing collagen gel contraction 
experiments with cardiac fibroblasts. (1) sGAG-coated gold nanorods and cells were suspended 
in an aqueous solution of neutralized collagen. (2) The solution was polymerized at 37 °C and 
5% CO2, and after an hour the gel was detached from the sides of the well and allowed to float 
freely in culture medium. (3) Over a 48 hour period the cell-mediated contraction of the gel was 
monitored. (C) Structures of chondroitin sulfate and heparin disaccharides, the polyelectrolytes 
used to surface functionalize the gold nanoparticles. 
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 In addition to its anticoagulation properties, heparin modulates fibrillogenesis and 
crosslinking of extracellular matrix proteins, including type I collagen24,25 and fibronectin26, 
and promotes assembly of other fibrillar proteins27. In addition, immobilized heparin has 
been used for the controlled release of bioactive polypeptides known to bind heparin28. CS 
also interacts with numerous proteins, including collagen; it was reported to increase the 
mechanical strength of type I collagen gels29 and to increase or decrease the rate of collagen 
polymerization30,31, depending on the concentration and degree of sulfation.  
 The objectives of the current study were to functionalize gold nanorods with heparin 
or CS and to investigate the interactions of these nanomaterials with cardiac cells (neonatal 
cardiac fibroblasts) and type I collagen. Implementing layer-by-layer assembly of 
polyelectrolyte multilayers, we were able to exploit the polyanionic properties of both 
heparin and CS to immobilize sGAG on the surfaces of the nanorods. The composite 
nanomaterials accelerated the polymerization of type I collagen and inhibited cell-induced 
contraction of collagen gels populated with cardiac fibroblasts. The results suggest that 
biological polyanions, such as heparin and CS, will be useful in the surface modification of 
nanoparticles for biological or therapeutic applications. 
8.2 Experimental Section 
8.2.1 Synthesis of Gold Nanorods:  Gold nanorods, aspect ratio 17.8 ± 4.2 (length 392 ± 93 
nm, width 22 ± 3 nm), were prepared from a seed-mediated surfactant-directed approach 
described previously32-34.  Briefly, spherical gold seed particles were synthesized by the 
reduction of an aqueous solution containing 2.5 x 10-4 M chloroauric acid (HAuCl4·3H2O) 
(Aldrich) and 0.1 M Ultrapure hexadecyltrimethylammonium bromide (CTAB) (Sigma) by 
0.01 M ice-cold sodium borohydride (NaBH4) (Aldrich).  After 15 minutes, this seed was 
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used in a three step seeding procedure to prepare gold nanorods. Two test tubes each 
containing 9 mL of growth solution consisting of 0.1 M CTAB and 2.5 x 10-4 M HAuCl4 
were prepared and labeled as test tube A and B.  A third 90 mL growth solution was also 
prepared in a 125 mL Erlenmeyer flask. Fifty mL of a 0.1 M ascorbic acid (Aldrich) solution 
was added to each of the test tubes, and 500 µL 0.1 M ascorbic acid was added to the flask. 
Next 1.0 mL of the 3.5 – 4 nm seed solution was added and mixed with test tube A. After 15 
seconds 1.0 mL of the solution in test tube A was added to B and mixed thoroughly. Thirty 
seconds after the addition to test tube B the entire nanoparticle solution from B was poured 
into the growth solution in the flask and mixed.  The solution was allowed to sit overnight 
(12-14 hours).  The next day purple supernatant was decanted leaving the rods at the bottom 
of the flask.  The rods were then resuspended in 20 mL of deionized water and purified by 
centrifugation [4000 relative centrifugal force (RCF) for 5 minutes]. Absorption spectra of 
nanorod solutions were acquired using a Cary 500 Scan UV-vis-near-IR spectrometer. 
Transmission electron micrographs were acquired using a Hitachi H-8000 transmission 
electron microscope.  TEM grids were prepared by placing 8 mL of the purified particle 
solution on a carbon-coated copper grid and evaporating the solution at room temperature. 
Average particle dimensions were obtained by measuring at least 100 particles per sample. 
 
8.2.2 Layer by Layer (LbL) Polyelectrolyte Deposition:  Aliquots (1.5 mL) of as-prepared 
gold nanorods were placed in 1.5 mL microcentrifuge tubes and centrifuged once at 4000 
RCF for 5 min.  A pellet of gold nanorods was formed at the bottom of the microcentrifuge 
tubes.  The supernatant was slowly removed without disturbing the pellet.  For 
polyelectrolyte coating experiments, two pellets were combined in 1 mL of deionized water. 
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Stock solutions of poly(sodium-4-styrene) sulfonate (PSS, Aldrich), 
poly(diallyldimethylammonium) chloride (PDADMAC,  Aldrich), CS (Aldrich, Mw = 15~30 
kDa), and heparin (Aldrich, Mw = 3~30 kDa), all at 10 mg mL-1 concentration, were prepared 
in 1 mM aqueous NaCl solution.  To the microcentrifuge tubes containing 1 mL concentrated 
gold nanorods, 100 mL of 10 mM NaCL and 200 mL of PSS stock solution were added 
simultaneously.  The solution was allowed to shake during the 30 min. adsorption time, after 
which the excess polymer in the supernatant was removed by centrifugation at 4000 RCF for 
5 min.  The resulting pellet was redispersed in 1 mL of deionized water and the process was 
repeated two more times with PDADMAC first then with either heparin or CS.  The charge 
on the nanorods was measured using a ZetaPALS zeta potential analyzer (Brookhaven 
Instruments Corporation). 
8.2.3 Collagen fibrillogenesis:  The kinetics and extent of collagen polymerization were 
determined spectrophotometrically35. Pepsin-extracted, acid-solubilized bovine type I collagen 
(Inamed) at 3.1 mg mL-1 concentration was neutralized on ice with 0.2N N-2-
hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES), pH 9.0,  and 10X phosphate-
buffered saline (PBS) in volumetric ratios of 8:1:1, respectively. The neutralized collagen was 
mixed with concentrated solutions of sGAG-coated gold nanorods or soluble sGAG in 18MW 
water, serially diluted in untreated collagen, and 100 mL portions were then added to the wells of 
a 96-well microplate in duplicate. The final concentration of type I collagen in these experiments 
was 2.2 mg mL-1, the final concentrations of soluble sGAG were 0-200 mg mL-1, and the final 
concentrations of gold were 0-337 ng mL-1 (0~200 pM in particles). The absorbance at 400 nm 
was recorded every 60 s for 1 h at 37 ºC  in a temperature-controlled microplate 
spectrophotometer (Bio-Rad). Absorbance measurements were corrected for initial absorbance 
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(t=0) by substraction prior to analysis. Equilibrium absorbance (Aeq), a measure of the extent of 
collagen polymerization related to fibril size, was calculated as the mean absorbance of the final 
5min., and a polymerization time constant, t50, was calculated as the time to 50% of the 
equilibrium absorbance. Data were analyzed for statistically significant differences between 
groups by the general linear model and Dunnett’s post-hoc test using MiniTab ver. 15. 
 
8.2.4 sGAG release:  After polymerization, the collagen gels were washed with PBS for 72 h at 
37 ºC, and wash buffer was collected and replaced every 24 h. The collagen gels were 
subsequently dissociated in 100 mL ice-cold extraction buffer composed of 4 M guanidine HCl, 
10 mM 2-(N-morpholino)ethanesulfonic acid (MES), 50 mM sodium acetate, 5 mM 
ethylenediaminetetraacetic acid (EDTA), pH 6.5. Guanidine is a chaotropic agent useful for 
dissociating native and engineered extracellular matrices; it denatures proteins and has been used 
extensively for the extraction of biological polyanions, such as sGAG-bearing proteins 
(proteoglycans), from tissues. As such, it is also expected to solubilize sGAG at the surface of 
the nanorods. Nanorods were separated from the dissociated collagen by centrifugation at 20000 
RCF for 15 min. at 4 ºC. Washes and gel supernatants were then assayed for sGAG content in 
96-well plates according to a previously published method36. Briefly, 10 mL of each sample was 
mixed with 200 mL of dye buffer containing 46 mM dimethylmethylene blue (Polysciences), 41 
mM glycine, 41 mM NaCl, pH 3.0. Absorbance at 525 nm for each sample was measured in 
duplicate, and sample sGAG contents were determined from standards of chondroitin sulfate and 
heparin sulfate in PBS or 1:1 PBS:extraction buffer.  Data were analyzed by Student’s t-test, 
with statistically significant differences for p < 0.05. 
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8.2.5 Darkfield microscopy:  Thin films of collagen, collagen-sGAG, and collagen-nanorod 
composites were prepared for darkfield microscopy. Solutions of neutralized collagen were made 
as described above and then diluted 1:5 in ice-cold PBS. For each composition, 100 mL was 
placed on a microscope slide, covered with a #1.5 coverslip, and allowed to polymerize at 37 ºC 
for 30 min. The samples were imaged through 20x air darkfield optics on a Nikon E600 with a 
mercury vapor lamp light source (EXFO). Image gamma values were adjusted to enhance 
contrast using ImageJ. 
Collagen gel contraction 
 For collagen gel contraction experiments, cardiac fibroblasts were isolated from 4 day 
old neonatal rats as previously described37. Whole hearts were aseptically dissected from the 
animals, minced in Krebs-Ringer bicarbonate buffer, digested with 100 U mL-1 collagenase, 
and mechanically dissociated by passing through a 14 gauge cannula. Digests were moved to 
T75 flasks, and fibroblasts were isolated by attachment to the flasks over 2 h. Cells were 
expanded through passage 2 or 3 in Dulbecco’s Modified Eagle Medium (DMEM) 
supplemented with 10% newborn bovine serum, 5% fetal bovine serum, 100 U mL-1 
penicillin G, 100 mg mL-1 streptomycin, and 10 mg mL-1 gentamicin. Following 
trypsinization and counting, cells were suspended in cold, neutralized type I collagen doped 
with or without sGAG-coated gold nanorods or soluble sGAG. Final concentrations of 
collagen, sGAG, and nanorods were similar to those in the polymerization assays, and the 
final cell density was 200,000 cells mL-1. Cell-collagen suspensions were moved to 24-well 
tissue culture plates preadsorbed with 5% bovine serum albumin (BSA)/DMEM and allowed 
to polymerize in a 37ºC, 5% CO2, humidifed incubator. After 1 h, cell-collagen constructs 
were detached from the wells in 1 mL serum-free media composed of DMEM supplemented 
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with 0.5% BSA, 1 mg mL-1 insulin, 0.55 mg mL-1 transferrin, 0.5 mg mL-1 sodium selenite, 
82 mg mL-1 ascorbic acid 2-phosphate, and antibiotics as listed above. Images of contracting 
gels were captured over 48 h with a digital camera, and gel areas were measured using 
ImageJ. Culture media was replaced after 24 h. After 48 h, some constructs were fixed in 4% 
paraformaldehyde for confocal microscopy. Alternatively, contructs were incubated with the 
Alamar Blue reagent according to the manufacturer’s instructions for another 24 h. 
 
8.2.6 Fluorescent staining and confocal microscopy:  Fixed constructs were permeabilized 
with 0.01% Triton X-100 in PBS, and stained with 1 U mL-1 rhodamine-phalloidin, a compound 
that fluorescently labels the cell’s actin cytoskeleton, and 1 mg mL-1 4',6-diamidino-2-
phenylindole (DAPI), a DNA-intercalating dye that labels the cell’s nucleus. Constructs were 
subjected to confocal laser scanning microscopy with a Zeiss 510LSM microscope and 40x and 
63x oil immersion objectives. Rhodamine phalloidin and DAPI were excited by 543 nm and 405 
nm lasers, respectively, and detected via appropriate emission filters. The collagen network and 
gold nanoparticles were detected by reflected light38 from either a 488 nm or 633 nm laser line, 
respectively. Images were adjusted for brightness and contrast in ImageJ, and an anisotropic 
diffusion algorithm39 was implemented to reduce noise in images of 488 nm reflectance.  
 
8.3 Results and discussion 
 In the present work, the interactions of sGAG-modified nanoparticles with type I 
collagen were explored (Figure 8.1). Collagen is the most abundant protein in the human 
body, is synthesised in vivo primarily by fibroblasts, and is localized almost exclusively in 
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the extracellular space as an insoluble network. At the molecular level, type I collagen 
exhibits a rod-like triple helicle conformation; these molecules self-asssemble into larger 
structures, termed fibrils, through a process involving distinct phases of nucleation, 
longitudinal growth, and lateral accretion40-42. The resulting collagen networks support cell 
attachment and bear mechanical loads, and collagen gels have been used extensively as in 
vitro models of wound healing/contraction and as scaffolds for tissue engineering43.  
 Does the presence of nanomaterials alter the fundamental self-assembly process of 
collagen? To answer this question, gold nanorods of aspect ratio 18 ± 4 (length 392 ± 93 nm, 
width 22 ± 3 nm; Figure 8.1), were prepared in aqueous solution using a seed-mediated 
surfactant-directed approach previously described32-34 and purified by centrifugation and 
washing. The resulting rod solution gave a zeta potential (effective surface charge) of +36.89 
± 1.40 mV. Using layer-by-layer assembly44, three layers of oppositely charged 
polyelectrolytes were deposited on the surface of the nanorods starting with anionic 
polystyrene sulfonate, followed by cationic poly(diallyldimethylammonium) chloride, and 
terminating in either heparin or CS, both of which are anionic. The deposition of the 
polyelectrolytes on the surface of the nanoparticle was monitored by both UV-vis 
spectroscopy and zeta potential measurements. The final charge on the nanorods was -20.62 
± 1.32 mV for heparin coated nanorods and -25.02 ± 1.33 mV for CS coated nanorods. 
Figure 8.2 shows the UV-vis spectra of the gold nanorods both uncoated and coated with 
polyelectrolytes. The uncoated gold nanorods have a transverse plasmon band at 506 nm and 
a longitudinal plasmon band at 1855 nm32-34. These plasmon bands arise from the conduction 
band electron oscillations across the short axis (transverse) and long axis (longitudinal) of 
the particles upon visible light irradiation45,1. There is a small red-shift in the transverse 
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plasmon band maxima as a function of the polyelectrolyte coating, consistent with previous 
reports44. The transverse plasmon band also shows no broadening, suggesting minimal 
nanorod aggregation after polyelectrolyte adsorption.   
 
 
 
 
 
 
 
175 
 
Figure 8.2 Morphology and UV-Vis spectra of gold nanorods. (A) Representative TEM of 
uncoated (as-prepared) nanorods. Scale bar = 100 nm. (B) Spectra showing the red-shift of the 
transverse plasmon band as a function of polyelectrolyte coating. Black curve: uncoated gold 
nanorods; blue curve: CS-coated gold nanorods; red curve: heparin-coated gold nanorods. 
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 Consistent with previous reports31,46, free soluble heparin and CS (Figure 8.1) 
exhibited dose-dependent perturbations of type I collagen polymerization (Figure 8.3A-B, 
Table 8.1). At concentrations between 0.2-20 mg mL-1, soluble heparin significantly reduced 
the lag (nucleation) phase of collagen polymerization compared to controls (p<0.05),  and 
appeared to alter the equilibrium absorbance of the collagen although these differences failed 
to reach statistical significance. At 200 mg mL-1, soluble heparin drastically interfered with 
collagen polymerization; these gels failed to fully polymerize and were easily disrupted. 
Soluble CS had more subtle effects on collagen polymerization; over the range of 0.2-20 mg 
mL-1, collagen-sGAG composites had slightly, but significantly, higher t50 than controls and 
similar Aeq. At the highest concentration examined, soluble CS significantly reduced t50 
compared to controls. Collectively, these data demonstrate the complex dose-dependent 
effects of soluble sGAG on bulk measures of collagen polymerization and provide important 
baseline data for comparison with collagen gels doped with sGAG-functionalized gold 
nanorods. 
 
 
 
 
 
 
 
 
 
177 
Table 8.1 Polymerization time constants (50) and equilibrium absorbances (Aeq) for type I 
collagen doped with various concentrations of soluble sGAG or sGAG-functionalized gold 
nanorods. Values of bulk sGAG concentration ([sGAG]) for coated nanorods were estimated 
from the measured dimensions of the nanomaterials and published values of the molecular 
dimensions of CS and heparin. 50 was calculated as the time to 50% of the equilibrium 
absorbance. Aeq was normalized to controls. Data are mean (S.D.) for 6 samples from 3 
experiments 
 
 
 
 
 
 
 
 
groups and exhibited slightly reduced Aeq of polymerized type I
collagen, but had no significant effect on the s50 of
fibrillogenesis.‡
Taken together, these results suggest that sGAG-coated
nanomaterials promoted aggregation of the collagen. Unlike as-
prepared nanorods, the sGAG-functionalized nanorods consis-
tently reduced the duration of the lag phase of collagen
polymerization. Collagen monomers self-associate to form
aggregates during the lag phase, and a reduction in s50 indicates
that aggregates formed more rapidly. Other groups have
described similar nanoparticle-induced perturbations in protein
polymerization and aggregation. Organic nanoparticles of
varying hydrophobicity and size (70 nm and 200 nm in diameter)
accelerated polymerization of b2-microglobulin, a protein
involved in dialysis-related amyloidosis.18 In contrast, similar
copolymeric particles (40 nm diameter) retarded polymerization
of Alzheimer’s disease-associated amyloid b protein.20 The
sGAG-coated gold nanorods used in this study may have
promoted nucleation by increasing the number or the size of
nuclei during the lag phase of collagen polymerization. Collagen
monomers contain clusters of basic amino acids49 that are
available to electrostatically bind the sGAG-coated nanorods.
Such binding would afford the rapid accumulation of collagen
monomers at the surface of the nanorods to promote the
formation of more and/or larger aggregates. The effects of
nanoparticles on protein polymerization/aggregation appear to
be specific to each nanoparticle-protein pair and involve
recruitment of protein monomers to the nanoparticle
surfaces.16,17
sGAG-functionalized gold nanorods also significantly reduced
the equilibrium spectrophotometric parameter Aeq below that of
controls, an effect not observed with free sGAG or as-prepared
Fig. 3 Polymerization curves for type I collagen doped with (A) soluble heparin, (B) soluble chondroitin sulfate, (C) heparin-coated gold nanorods, or (D)
chondroitin sulfate-coated gold nanorods. Measurements were corrected for absorbance at t ¼ 0. Data are mean " S.D. for 6 samples from 3 experiments.
Table 1 Polymerization time constants (s50) and equilibrium absor-
bances (Aeq) for type I collagen doped with various concentrations of
soluble sGAG or sGAG-functionalized gold nanorods. Values of bulk
sGAG concentration ([sGAG]) for coated nanorods were estimated from
the measured dimensions of the nanomaterials and published values of
the molecular dimensions of CS and heparin. s50 was calculated as the
time to 50% of the equilibrium absorbance. Aeq was normalized to
controls. Data are mean (S.D.) for 6 samples from 3 experiments
[sGAG]/
mg mL#1
[Au]/ng
mL#1 s50/min.
Normalized
Aeq
Control 0 0 18.2 (0.3) 1 (0.01)
+ Soluble sGAG:
Heparin 200 0 20.9 (3.9) 0.58 (0.24)a
20 0 9.0 (0.6)a 1.12 (0.10)
2 0 13.4 (1.1)a 0.88 (0.02)
0.2 0 13.7 (0.8)a 0.87 (0.01)
CS 200 0 16.2 (0.6)a 1.00 (0.03)
20 0 20.7 (0.4)a 1.00 (0.01)
2 0 22.1 (0.5)a 1.00 (0.02)
0.2 0 20.6 (0.5)a 0.98 (0.01)
+ sGAG-functionalized Au nanorods:
Heparin-Au 10 337 10.7 (0.6)a 0.72 (0.03)a
5 169 13.2 (0.5)a 0.81 (0.03)a
2.5 84 13.3 (0.4)a 0.84 (0.04)a
CS-Au 10 337 12.4 (0.9)a 0.77 (0.09)a
5 169 14.5 (0.7)a 0.85 (0.07)
2.5 84 14.7 (0.7)a 0.89 (0.08)
a Denotes p < 0.05 versus control.
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Figure 8.3 Polymerization curves for type I collagen doped with (A) soluble heparin, (B) soluble 
chondroitin sulfate, (C) heparin-coated gold nanorods, or (D) chondroitin sulfate-coated gold 
nanorods. Measurements were corrected for absorbance at t = 0. Data are mean ± S.D. for 6 
samples from 3 experiments. 
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 Collagen gels containing various doses of gold nanorods bearing heparin or CS also 
exhibited dose-dependent differences in polymerization (Figure 8.3C-D, Table 8.1). Using 
mean particle sizes (assuming complete particle coverage) and published molecular 
dimensions of heparin47 and CS48, we estimated that the highest concentration of 
nanomaterials contained ~10 µg mL-1 sGAG. Similar to soluble heparin, heparin-coated 
nanomaterials significantly reduced the lag phase of polymerization as indicated by t50 values 
(p<0.05). In contrast to soluble heparin, heparin-coated nanorods significantly reduced Aeq to 
72-84% of controls. All examined doses of CS-coated nanorods also significantly reduced t50 
compared to controls, and the highest dose of CS-coated nanorods significantly reduced Aeq 
to 77% of controls. This is in contrast to soluble CS, which had no effects on Aeq and 
reduced t50 only at the highest concentration examined. As-prepared nanorods lacking any 
coating present a layer of positively charged cetyltrimethylammonium groups and exhibited 
slightly  reduced Aeq of polymerized type I collagen, but had no significant effect on the t50 
of fibrillogenesis†. 
 Taken together, these results indicate that presentation of sGAG on the surface of the 
nanomaterials modulated sGAG-collagen interactions and collagen-nanorod interactions. 
Unlike soluble sGAG, the sGAG-functionalized nanorods consistently reduced the nucleation 
time during the self assembly of collagen gels, and other groups have described similar 
nanoparticle-induced perturbations in protein polymerization and aggregation. Organic 
nanoparticles of varying hydrophobicity and size (70 nm and 200 nm in diameter) 
accelerated polymerization of b2-microglobulin, a protein involved in dialysis-related 
amyloidosis18. In contrast, similar copolymeric particles (40 nm diameter) retarded 
polymerization of Alzheimer’s disease-associated amyloid b protein20. The effects of 
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nanoparticles on protein polymerization/aggregation appear to be specific to each 
nanoparticle-protein pair and involve recruitment of protein monomers to the nanoparticle 
surfaces17,16.  
 Darkfield microscopy revealed the effects of soluble sGAG and sGAG-coated 
nanorods on the morphology of the polymerized collagen network (Figure 8.4A). Controls 
exhibited a meshwork of interconnected fibrils with a distinct pore space. The addition of 20 
mg mL-1 soluble heparin induced the formation of collagen aggregates surrounded by regions 
of relatively large pores. Aggregates and surrounding regions of low fibril density were also 
observed with the addition of 337ng mL-1 heparin-coated nanorods, but the size of the 
collagen fibrils appeared to be reduced compared to controls. Interestingly, the nanomaterials 
appeared to be entrained within the collagen network as individual particles within fibrils and 
as part of the collagenous aggregates, suggesting a strong interaction between the particles 
and the collagen. The addition of soluble CS had little effect on the morphology of the 
polymerized collagen, whereas collagen doped with CS-coated nanorods exhibited a much 
finer meshwork marked by qualitatively shorter fibrils and smaller pores compared to 
controls. These results support the idea that sGAG-collagen interactions are altered when the 
sGAG is bound to the surfaces of nanoparticles.  
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Figure 8.4 Darkfield (A) and confocal reflectance (488 nm laser) (B) images of type I collagen 
gels doped with 20 µg mL−1 soluble sGAG or 337 ng mL−1 sGAG-functionalized gold nanorods. 
Darkfield images show regions of intense, punctate and diffuse signal indicating the locations of 
the gold nanoparticles. Confocal images are of gels cultured with cardiac fibroblasts for 48 h. In 
A, scale bar = 100 µm. In B, scale bar = 50 µm, and the optical section thickness is 1.5 µm. 
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 Confocal microscopy showed that both heparin- and CS-coated nanoparticles were 
integrated with the polymerized collagen network (Figure 8.4B). The nanorods were 
observed as punctate regions of high reflectance at the intersections of fibrils and along 
spanning fibrils. This is consitent with our previous report describing the entrainment of 
nanorods terminated with a synthetic polyanion, PSS, in collagen fibrils via confocal and 
electron microscopy12. Differences in collagen network morphology with sGAG-nanoparticle 
treatments were also observed with confocal in this study, including larger pores in the 
presence of heparin-coated nanoparticles and a finer meshwork with smaller fibrils in 
collagen doped with CS-coated nanoparticles. These results underscore an important role for 
the nanoparticle platform in these studies: to immobilize the sGAG within the extracellular 
matrix. 
 Type I collagen has been shown to have heparin binding sites49, and chondroitin 6-
sulfate, the variety of CS used in this study, was found to bind at periodic sites on type I 
collagen fibrils50. We reasoned that immobilization of sGAG within the collagen matrix 
could be enhanced through electrostatic association with nanoparticles. To investigate this 
possibility, release and retention of sGAG from cell-free collagen gels were measured over a 
72 h period using a colorimetric assay. The fractions of retained sGAG were calculated from 
the sGAG contents of saline washes and dissociated gels (Figure 8.5). For collagen gels 
loaded with 200 mg mL-1 free heparin or CS, sGAG release decayed over the 72h period. 
After 72 h,  ~17% of the initial CS was retained in the collagen gel. Gels loaded with heparin 
at this concentration were flocculent and residual sGAG contents could not be determined. 
Gels with lower initial concentrations of heparin (0.2-20 mg mL-1) exhibited up to 88% 
retention, whereas these doses of soluble CS were retained only up to ~20%, indicating that 
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heparin has a higher affinity for the collagen in this system. Interestingly, the fraction of CS 
retained was significantly higher for gels containing CS-coated nanorods (29-44%) than for 
gels containing soluble CS (p < 0.05), and this difference was not apparent in heparin-
containing gels. These results suggest that association with the nanomaterials enhanced 
retention of CS within the extracellular matrix, and such immobilization may be useful in 
prolonging the bioactivity of CS in vivo. 
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Figure 8.5 Fractions of heparin (A) and CS (B) retained (after 72 h) in type I collagen gels 
doped with indicated doses of soluble sGAG or sGAG-functionalized gold nanorods. Retained 
sGAG for gels doped with 200 µg mL−1 heparin was not tested (NT) because these gels could not 
be removed from the wells intact. Data are mean + S.D. for 4 samples from 2 experiments. * 
indicates p < 0.05 vs. all concentrations of soluble CS. 
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 A collagen gel contraction assay was used to compare the effects of soluble sGAG 
and sGAG-coated nanorods on cell (fibroblast) behavior. Living fibroblasts, when placed 
into a collagen gel, remodel their local environment, and in this standard assay contract the 
volume of the collagen gel.  In these studies, cell-mediated remodeling of the composite 
materials was quantified by measuring changes in gel area (Figure 8.6), as we have done 
before12. Control constructs contracted the gels to ~70% of the initial area over 48h. The 
addition of 2 or 20 mg mL-1 soluble heparin reduced contraction to ~85% of the initial area, 
whereas similar doses of CS had no effect on contraction. Heparin has been shown to 
potently inhibit collagen gel contraction in other cell types, including endothelial cells,51 
dermal fibroblasts52, intestinal smooth muscle cells53, and glomerular mesangial cells54. 
These results are also consistent with previous reports describing little effect of CS on 
collagen gel contraction by dermal fibroblasts and keratinocytes55.  
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Figure 8.6 Cardiac fibroblast-mediated contraction of type I collagen gels doped with soluble 
sGAG or sGAG-coated gold nanorods. Data are means of 9 samples from 3 experiments. Error 
bars are omitted for clarity. 
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 The addition of 337 ng mL-1 heparin- or CS-coated nanorods also substantially 
reduced contraction of the collagen gels. The differences in gel contraction did not appear to 
be due to cytotoxic effects, since spectrophotometric measurement of the cell-based 
reduction of resazurin to resorufin indicated similar metabolic activity between groups (data 
not shown). These data show that, similar to PSS-coated nanorods12, sGAG-functionalized 
nanoparticles can modulate fibroblast-mediated matrix remodeling without interfering with 
cell viability. Interestingly, presentation of CS on the surface of the nanorods conferred 
bioactivity that was not observed with free CS, suggesting that cells are sensitive to the 
retention and/or nanoscale clustering of CS in their environment.  
 The interactions of sGAG-functionalized nanorods with cells in 3D constructs were 
further investigated by confocal microscopy (Figure 8.7). After 48h, control constructs 
exhibited spread cells and pericellular compaction of the collagen network, as indicated by 
regions of diffuse reflected light near the actin cytoskeleton. In constructs doped with 
heparin- and CS-coated nanorods, cells were also spread, but reflection from the collagen 
network was less intense, and punctate regions of high intensity reflected light revealed the 
presence of nanomaterials in the intra- and/or peri-cellular compartments. It has been shown 
previously that mammalian cells internalize gold nanorods, and the rates of internalization 
appear to be sensitive to nanomaterial surface chemistry56-58. These results suggest that 
presentation of heparin or CS on the surfaces of gold nanorods can also influence cell 
behavior in part via direct binding to the cell surface and/or endocytosis pathways. 
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Figure 8.7 Confocal images of cardiac fibroblasts in type I collagen gels doped with sGAG-
coated gold nanorods after 48 h of culture. Actin filaments (red) were stained with rhodamine-
phalloidin, and nuclei (blue) were stained with DAPI. Nanorods are indicated by intense regions 
of reflected light (from a 633 nm laser, shown in cyan). Lower intensity reflected light is from 
collagen fibrils. Scale bar = 25 µm, and the optical section thickness is 800 nm. 
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 Heparin and CS serve important functions in the growth, maintenance, and repair of 
human tissues. Numerous proteins contain heparin-binding motifs rich in basic amino acids 
that promote electrostatic binding with heparin and other sGAG, and such sGAG-protein 
interactions are required in the transmission of some signals to the cells59. In addition, cells 
are sensitive to nanoscale clustering of membrane receptors60 and their cognate extracellular 
ligands61-63. Thus, presentation of sGAG (or sGAG-binding factors) on the surfaces of 
nanomaterials, such as the sGAG-functionalized gold nanorods in these studies, may be 
useful for regulating cell behavior in vitro and in vivo.  
 
8.4 Conclusions 
We have demonstrated that natural polyanions from the sGAG family of polysaccharides can 
be immobilized on the surface of gold nanorods. sGAG-functionalized nanorods accelerated 
the assembly of type I collagen gels, and inhibited cell-mediated gel contraction in 3D 
culture without compromising cell viability. The nanomaterials were entrained within the 
forming collagen network, released little sGAG, and some were localized on/within 
fibroblasts. In vivo, these polyanions exert bioactivity via interactions with ECM proteins, 
such as collagen, and by binding polypeptides that promote the formation of new blood 
vessels64-66. Fibroblasts from the heart and other tissues exhibit a contractile phenotype 
during wound healing, and delivering sGAG-functionalized nanomaterials to sites of injury 
may be a useful strategy in curbing the accumulation of scar and promoting the regeneration 
of functional tissue. 
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